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ABSTRACT 
Purpose: The purpose of this investigation was to examine the effects of SR2W-1 
herbal supplementation on cycling performance, muscle and blood lactate, and 
various physiological parameters including blood glucose, heart rate (HR), rating 
of perceived exertion (RPE), oxygen consumption (VO2), expired ventilation 
(VE), respiratory exchange ratio (RER), and femoral artery blood flow. Methods: 
Seven recreational cyclists (Age: 26.7 ± 9.8 yrs, Height: 172.5 ± 13.3 cm, Weight:
67.1 ± 10.7 kg, and VO2max: 59.5 ± 11 mL/kg/min) performed 20-min of steady-
state cycling (~85% VO2max, 212.1 ± 25.0 W) followed by three 1-min high 
intensity intervals at VO2max workload (272.9 ± 26.9) with 30-sec active recovery 
periods at 100 watts.  Following intervals, a 15-min passive recovery period 
preceded a ride to fatigue at VO2max workload. Subjects completed trials on four 
occasions; preceding and following 21 days of 1000mg/d SR2W-1 (EXP) or 
1000mg/d placebo (PLA) assigned in random order.  The Wilcoxon Signed-Rank 
Test was used to compare change-scores from pre- to post- PLA and EXP 
conditions.  Results: No differences reported for any dependent variable and 
performance times were not different between PLA  (pre-PLA: 180 ± 48 s;  post-
PLA: 198 ± 56 s) and EXP (pre-EXP: 170 ± 57 s; post-EXP: 191 ± 50 s). 
Conclusion: Notwithstanding the small sample size, 3 weeks of SR2W-1 
supplementation does not appear to aid cycling performance, attenuate skeletal 




 Following the pioneering work of A.V. Hill and others, the Harvard 
Fatigue Laboratory opened in the fall of 1927 in Cambridge, Massachusetts with 
the purpose of examining fatigue in man under various environmental and 
working conditions.  Although the lab is no longer in existence, the complex 
nature of fatigue has necessitated continued work in this area, especially as it 
relates to fatigue from exercise.  Of the many physiological parameters implicated 
in exercise-induced fatigue, hydrogen concentration (pH) and lactate are two of 
the most widely studied.  
 High levels of blood lactate and associated reductions in pH are strongly 
associated with the onset of fatigue.  In 1907, Fletcher and Hopkins examined 
lactic acid levels in working frog muscles and stated that “an acid reaction of the 
muscle is, as most agree, a constant mark of the fatigued condition and a constant 
condition of the state of rigor,” providing evidence that acidity has been 
associated with decreased function and fatigue for over a century (33).  The 
relationship  between exercise-induced blood acidity and intensity in man was 
elucidated by Margaria et al. in 1933 (63).  It is now known that  carbohydrate 
metabolism (glycolysis) increases with exercise intensity to rapidly re-synthesize 
ATP for contracting skeletal muscle.  A high rate of glycolysis leads to pyruvate 
production that exceeds the speed at which pyruvate can be aerobically 
metabolized in the mitochondria, thus resulting in the ‘anaerobic’ formation of 
lactic acid.  Once lactic acid is formed it immediately dissociates into lactate and 









interferes with function 






Co-transport of lactate and H+ into 
blood allows for continued  
muscular function 
Figure 1.1 - Lactate Dynamics
 Lactic acid’s role in fatigue has been debated due to a lack of supporting 
evidence regarding lactic acid’s proton contribution and the positive energetic 
properties of lactate.  However, the deleterious effects of pH on skeletal muscle 
function are well-documented.  In-vitro skeletal muscle experiments have shown 
that low intra-muscular pH can interfere with several reactions within the muscle 
cell, inhibiting function and causing fatigue (13, 30, 59).  It has also been 
suggested that hydrogen ion accumulation may inhibit the release of calcium from 
the sarcoplasmic reticulum and interfere with the transmission of neural impulses 
which can also decrease function (45).  Although there are other potential sources 
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of muscular fatigue which can hinder performance such as fatigue of the central 
nervous system, psychological factors, and inorganic phosphate accumulation in 
the muscle cell, acidosis is often regarded as the most prevalent source of fatigue 
during intense exercise.
 Because intense exercise is associated with a drop  in pH and subsequent 
fatigue, athletes can benefit from strategies that mitigate the acidifying effect of 
exercise to enhance their performance.   In 1924, A.V. Hill acknowledged the 
importance of tissue and blood buffers and their effect on muscular effort (39). 
As early as the 1930’s, researchers experimented with induced alkalosis and its 
effect on performance.  They hypothesized that by increasing blood alkalinity, 
more lactic acid could be produced implying more energy  from anaerobic 
glycolysis and achievement of higher intensities (64).  After being largely ignored 
for nearly 30 years due to initial null findings, a resurgence of research in the 
1970‘s began to indicate that manipulating extracellular buffering capacity can 
impact intracellular pH.  Bicarbonate supplementation became the predominant 
mode of inducing blood alkalinity since the bicarbonate buffer system is a 
primary source of blood’s buffering capacity.   Research shows that increasing 
blood pH with bicarbonate increases the rate of lactate and hydrogen efflux from 
muscle cells despite the sarcolemma’s relative impermeability to bicarbonate (18, 
43, 48, 88, 92).  This suggests that hydrogen ion efflux from the cell works down 
a concentration gradient.  Conceptually, an increased concentration gradient 
facilitated by changes in extracellular lactate/H+ should allow for more lactate/H+ 
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transport from the active skeletal muscle, thereby delaying fatigue.  As a result, 
lactate/H+ supplement research has become prevalent due to its potential 
performance-enhancing benefits.                       
 SR2W-1 is a commercially  available herbal supplement designed to 
improve high-intensity  exercise performance.  Research supporting the efficacy of 
SR2W-1 is promising as two investigations have demonstrated that SR2W-1 
prolongs exercise endurance and promotes lactate clearance after exhaustive 
exercise as well as improves overall performance (1, 57).  However,  the two 
existing SR2W-1 studies were not peer reviewed nor were they cross-over, 
placebo-controlled, double-blind designs examining multiple factors.  The 
comprehensive nature of our studies’ protocol is more likely to reveal a 
mechanism of action.  If the ergogenic effects of SR2W-1 are facilitated by 
factors related to acid-base balance, the effects are likely  mediated by one or both 
of the following physiological mechanisms: 1. Direct effect on lactate and 
hydrogen production in skeletal muscle or intracellular buffering, and 2. Indirect 
effect on skeletal muscle lactate and pH through modifications to blood lactate 
and/or pH.  Although there has been a sparse amount of information gathered on 
the effects of herbal supplements on blood flow, the latter mechanism could be a 
result of blood flow distribution due to it’s role in lactate exchange (34, 96).
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Aims and Hypotheses
Aim 1 - To determine if 21 days of SR2W-1 supplementation improves high-
intensity cycling performance compared to a placebo.
Hypothesis 1 - SR2W-1 will improve cycling exercise performance compared to a 
placebo.
Aim 2 - To determine if 21 days of SR2W-1 supplementation alters blood lactate 
levels during cycling exercise compared to a placebo.
Hypothesis 2 - SR2W-1 will reduce blood lactate levels during exercise compared 
to a placebo.
Aim 3 - To determine if 21 days of SR2W-1 supplementation alters blood lactate 
levels during 15 minutes passive recovery compared to a placebo.
Hypothesis 3 - SR2W-1 will reduce blood lactate levels during high-intensity 
intervals when compared to a placebo.
Aim 4 - To determine if 21 days of SR2W-1 supplementation alters skeletal 
muscle lactate levels during 15 minutes of passive recovery compared to a 
placebo.
Hypothesis 4 - SR2W-1 will decrease skeletal muscle lactate levels and increase 
muscle pH compared to a placebo.
Aim 5 - To determine if SR2W-1 alters femoral artery  blood flow during 15 
minutes of passive recovery compared to a placebo.
Hypothesis 5 - SR2W-1 will increase femoral artery blood flow when compared to 
a placebo.
5
Significance of the Study
 Although initial studies have indicated that SR2W-1 supplementation has 
positive effects on lactate levels and performance, the current study  will be the 
first to implement a randomized, placebo-controlled, cross-over design.  Thus, the 
finding will provide a strong scientific foundation for the relative efficacy  of the 
supplement which will serve to better inform coaches and athletes.  Further, the 
physiological effect of SR2W-1, combined with the performance outcome, will 
provide further insight in to the role of blood flow, blood lactate and pH, and 
skeletal muscle lactate and pH as factors in fatigue.
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CHAPTER TWO
REVIEW OF THE LITERATURE
Objectives
 The objectives of this chapter are to provide an overview of how: 1) 
lactate affects skeletal muscle fiber function in animals independent of pH, 2) pH 
affects skeletal muscle fiber function in animals, 3) lactate and pH affects cycling 
and leg exercise in man, 4) sodium bicarbonate/citrate supplementation affects 
cycling performance and, 5) herbal supplementation affects cycling performance.
Lactate and Skeletal Muscle Fiber Contractile Function in Animals
 Lactate and hydrogen ions are by-products of anaerobic glycolysis, 
produced in excess when exercise intensity  exceeds the aerobic system’s ability  to 
provide energy.  Once lactate is produced in the cytoplasm of a muscle cell (fiber) 
it is: 1) released into the blood and used by the liver as a gluconeogenic precursor 
2) shuttled to an adjacent muscle fiber and used for immediate energy  provision or 
stored as glycogen, 3) released into the blood and taken up by other skeletal 
muscle fibers and the heart, or 4) excreted in urine or sweat.   The production of 
hydrogen ions is generally associated with fatigue while lactate itself is 
considered a fuel.  However, some research does indicate that  lactate may inhibit 
muscle function independent of pH in animal fibers.
 Research on the effects of lactate concentration on the contractile 
machinery, and consequently  force production, is contentious.  Two studies 
concluded that lactate has no effect on excitation-contraction coupling (22, 79) 
and may  actually promote the maintenance of submaximal and maximal dynamic 
force and maximal isometric force (49).  However, other studies have shown that 
lactate significantly decreases tetanic force (5, 87) and tension development of 
animal muscle fibers (28, 40). 
 On a mechanistic level, numerous studies have examined the influence of 
lactate concentration on the functionality of animal sarcoplasmic reticulum (SR), 
a muscle fiber organelle responsible for releasing the calcium necessary  for 
contraction.  Andrews et al. found that lactate exposure reduces calcium uptake of 
the SR which could theoretically decrease calcium availability for contraction for 
subsequent contractions (6).  Lactate has also been shown to inhibit  both caffeine-
induced calcium release (22, 32) and calcium-induced calcium release by  the 
sarcoplasmic reticulum (32), thus interfering with contractile function.  In 
contrast, others have indicated that lactate either increases calcium-induced 
calcium release (6) or has no effect on the normal voltage-gated calcium release 
of the sarcoplasmic reticulum (22) since the physiological mechanism of calcium 
release is different than artificially  induced mechanisms.  More research is needed 
to determine the role of lactate on calcium dynamics of the SR.
 Although mechanisms for how lactate may inhibit muscle function have 
not been identified and lactate’s role as a source of fuel is widely  accepted, there 
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is still some evidence suggesting that the lactate anion may contribute to the 
skeletal muscle fatigue process.  However, research regarding the effect of high 
intracellular lactate on human muscle function in vitro is lacking and translating 
animal findings to human models is speculative, albeit not completely unrealistic.
9







Hogan et al. 
1995 (40)
Dog Gastroc • Infused with either 
  [La+] or placebo in situ
• Muscle stimulated via 
sciatic nerve for two 60-
minute period with 45-
minute rest in a step-wise 
fashion
• ↑ [La+] ↓ tension 
development in 
proportion with a change 
in muscle oxygen uptake
Andrews et 
al. 1996 (5)
Rabbit Psoas and 
Soleus
• Chemically skinned SMF 




for rabbits and humans
• ↑ [La+] ↓ Ca2 + 
activated force in fast-
twitch psoas and slow-
twitch soleus
• In supraphysiological 
  [La+] conditions (30-50 
mM), force returned to 
control levels
• ↑ [La+] ↓ muscle 
function and force of 
contractile apparatus, 
responsible for up to 1/3 
of force depression




• SR vesicles extracted
• Quantified Ca2 + efflux, 
ryanodine binding, and 
single Ca2 + channel 
dynamics in varying [La
+] environments
• ↑ [La+] ↓ Ca2 +  and 
caffeine induced Ca2+   
release
• ↑ [La+] ↓ Ca2 +- 
dependent binding of 
ryanodine to its receptor
• ↑ [La+] ↓ single-
channel caffeine-
activated Ca2 + release
Andrews and 





• SMF bathed in varying 
[La+] concentrations
•  SR loaded and depleted 
under different [La+] 
conditions
•  SR Ca2 + uptake ↓ most 
with 10 mM [La+] and 
less with 20 and 30 mM 
up to 60 seconds 
exposure
• Ca2 + induced Ca2 + 
release ↑ as [La+] ↑ at 
pCa 5 but not pCa > 8.5
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• Muscle incubated 
in 10, 20, 30, and 
50 mM [La+] at 21 
and 37 °C 
• Force output 
monitored
• ↓ tetanic force at ↑ extracellular 
[La+] levels especially at higher 
temperature









• Skinned SMF 





induced Ca2 + 
release from SR, 
and depolarization 
induced Ca2 + 
release evaluated
• [La+] small ↓ on contractile 
apparatus
• [La+] ↓ caffeine-induced Ca2 + 
release
• [La+] ↔ Ca2 + release from 
normal voltage gate mechanism









• Skinned SMF 
bathed in varying 
[La+] 
concentrations




dependent Ca2 + 
release, and Ca2 + 
leak from SR
• [La+] ↓ maximum Ca2 + activated 
force, Ca2 + sensitivity
• [La+] ↑ Ca2 + leak from SR 
• Inhibitors of [La+] transport did not 
alter effect of [La+] on excitation-
contraction coupling
• [La+] has small effect on Ca2 + 







• Skinned SMF 
bathed in varying 
[La+] 
concentrations
• Measured Ca2 + 
uptake, contractile 
apparatus function, 
twitch and tetanic 
force in presence 
of [La+] 
• [La+] ↔ Ca2 +  activation of 
contractile apparatus,  rate of rise 
or peak twitch and tetanic 
response, Ca2+   release of action 
potential, and Ca2 + uptake of SR
• [La+] ↔ excitation-contraction 
coupling
11







Erdogan et al. 
2002 (28) 
Rat Diaphragm • Muscle strips bathed in 
20 mM 
   [La+]  or placebo for 
20 minutes
• Muscle stimulated via 
phrenic nerve
• Evaluated resting 
membrane potential 
and amplitude of 
sarcolemma action 
potential
• [La+] ↓ mean tension 
development 
• [La+] ↔ resting 




Karelis et al. 
2004 (49)
Rat Plantaris Whole muscle bathed in 
saline or [La+] solution 
and stimulated for 60 
minutes
• [La+] infusion 
preserved submaximal 
dynamic force
• Maximum dynamic and 
isometric force higher 
at end of stimulation 
period with [La+]
• [La+] ↔ muscle 
glycogen utilization or 
neuromuscular fatigue
SMF = Single Muscle Fiber,  SR = Sarcoplasmic Reticulum, [La+] = Lactate 
Concentration, Ca2 + = Calcium, mM = Millimole,  ↑ = Increase, ↓ = Decrease, ↔ 
= No Change
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pH and Skeletal Muscle Fiber Contractile Function in Animals
 pH is the negative logarithm of hydrogen ions in solution.  In other words, 
pH describes how acidic or basic a solution is.  At  rest, human skeletal muscle 
operates optimally at approximately 7.0 pH units.  Heavy  muscular work (i.e. 
exercise) disrupts homeostasis by  reducing pH.  Numerous studies have evaluated 
whether or not decrements in skeletal muscle pH impact function of various 
animals in vivo and in vitro.  In 1906, Fletcher and Hopkins were amongst the first 
to identify that “lactic acid,” or an acidified condition of the muscle, affected the 
muscular function of amphibians.  Since then, many studies have been conducted 
with various animals, most of which finding that muscle acidification diminishes 
both muscle contractile velocity (16, 19, 24, 78, 98, 100) and peak isometric force 
(21, 30, 78, 90).  Additionally, the rate of relaxation and force recovery also 
appears to be impaired in fatigued and acidified skeletal muscle (12, 82, 98). 
Although acidosis may contribute to fatigue, Nielsen et al. speculated that it  might 
be a protective strategy due to its beneficial contributions to force recovery in the 
presence of elevated potassium (75).  This hypothesis is attractive, but Krisensen 
et al. found that acidosis is not protective under normal physiologic conditions 
(55).
 A primary weakness of the existing in vitro animal data is that  experiments 
are typically performed at non-physiological temperatures which makes 
interpreting the generalizability  of findings difficult.  For instance, both 
Westerblad et al. and Pate et al. found that acidification of animal muscle below 
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physiological   temperatures significantly reduced maximum shortening velocity 
while at normal temperature shortening velocity is actually  slightly increased (78, 
98).  There is also evidence that induced acidosis during experimentation does not 
mimic acidification caused by muscle fatigue from stimulation since there is a 
smaller decrease in stiffness of muscle when acidification is artificially  created 
(24).  Thus, methodological limitations make it difficult to apply these findings to 
in vivo human skeletal muscle function.
 From a mechanistic standpoint  there are many explanations for how 
lowered pH could induce muscle fatigue in animals.  Calcium release from 
sarcoplasmic reticulum (SR) vesicles has been shown to decrease during acidosis 
and high-lactate conditions through the Ryanodine calcium channel, a very 
specific channel in which binding is governed by compounds that stimulate 
calcium release and inhibition (31, 61).  However, other research using whole 
muscle fibers has shown that pH does not decrease calcium release from the SR, 
may leak more calcium in an acidotic state, and increase the amount of tetanic 
calcium available (14, 58).  Regardless of calcium availability, lowered pH 
reduces calcium re-uptake time from the myoplasm creating a longer duration of 
depolarization-induced response (58) and greatly reduces binding of calcium to 
troponin C, which inhibits the contractile machinery (14, 21, 30).  Finally, an 
acidified intramuscular condition may  affect certain reactions in the glycolytic 
cascade, which could inhibit  function.  In mouse and frog muscle, 
phopshofructokinase (PFK) is very sensitive to pH changes and acidosis reduces 
14
the affinity of PFK for fructose-6-phosphate (4, 93).  An abundance of research 
implicates pH as a cause of fatigue but the exact role of pH is unknown. 
15










• Frog limb muscles 
stimulated electrically in 
different anaerobic 
environments (hydrogen and 
nitrogen) at varying 
temperatures
• “Lactic acid” measures and 
muscle weights taken at 
different time points
• ↑ “lactic acid” levels  ↓ 
muscle function
• Muscle function ceased at 







• PFK extracted and placed in 
solution
• pH altered within 
physiological range 
• ↓ pH, ↓ affinity of PFK 
for F-6-P 







Skinned SMF stimulated in 
Ca2+ buffer solutions of 
consistent chemical 
composition at pH 6.5 or 7.0 
and 1 mM or 7 mM of  Mg2+
• ↔ Maximum tension at 
the same Mg2+  
concentration but ↓ at 
lower pH
• Greater ↓ of submaximal 







Skinned SMF stimulated  in 
solutions of varying free Ca2+ 
and pH
• Small acidosis ↑ Ca2 + 
content of SR and large 
acidosis ↓ Ca2 + content
• Acidosis ↓ maximum 
tension production  
•  H+ accumulation affected 





Frog Sartorius Muscles stimulated at 
different rates (0.2 - 2 trains/
second) in various 
extracellularly buffered 
solutions
• ↓ extracellular pH ↓ the 
rate of force recovery 
• ↔ rate of change from a 









• Whole muscle stimulated in 
control condition (C), 
metabolic acidosis (MA), or 
respiratory acidosis (RA)
• Bx pre and post perfusion
•  Analyzed for PPO2, PPCO2, 
pH, O2 saturation of Hb, Hb 
concentration, plasma 
HCO3-, arterial Hct, ATP, 
ADP, AMP, CP, and [La+] 
• [La+] release greatest in C
• Muscle Gly utilization and 
[La+] accumulation ↓ in 
MA and RA
• ↔ Muscle CP and ATP
• Acidosis ↓ isometric 
tension, aerobic, and 
anaerobic metabolism
16







Rabbit Psoas • SMF stimulated in buffers of 
differing pH, temperature, 
and chemical composition to 
determine MgATP, NADH, 
and ATPase activity
• ↓ pH at 3 mM PO4 ↓ 
PO4 by 45%, ↓ 
maximum velocity of 
contraction, ↓ ATPase 
activity by 25-30%
• Curve of the force-
velocity relationship ↔ 





• Muscle strips bathed in 
Ringer solution in 
temperature-controlled 
chamber
• Stimulated to fatigue at high 
and low frequencies and time 
intervals
• Intracellular pH measured
• ↔  high low frequency 
groups and recovery of 
pH
• Recovery of pH highly 
correlated to the 
recovery of peak tetanic 
tension
• Fatigue from high and 
low frequency partially 
due to effects of 







• SMF perfused in Ringer 
solution of varying pH  (6.00 
- 7.99)  and constant HCO3 
• Intracellular pH and 
temperature measured 






• SMF placed in standard or pH 
lowering solution at constant 
temperatures 
• Stiffness measured 
throughout isometric tetanus
• SMF fatigued via continual 
stimulation or chemical 
solution 
• Caffeine introduced to 
determine whether failure of 
activation of contractile 
system caused fatigue
• Chemical and 
mechanical fatigue did 
not duplicate contractile 
behavior of fatigued 
muscle 
• Smaller stiffness ↓ from 
artificially lowered pH 
versus fatigue
• Induced acidification ↑  
rate of rise of stiffness 
with  ↓  rise of force
• Force-producing 
capability of attached 
cross bridges ↓ in 
fatigued condition 
despite ↔ in activation
17









• Fiber bundles superfused 
in acid or control 
solutions at 22°C
• Electrodes monitored pH
• SMF analyzed for ATP,  
CP, G-6-P, and F-6-P
Acidosis slowed glycolysis 
by ↓ conversion of F-6-P 






• SMF placed in Ca2+, Na, 
K+ solutions and 
stimulated chemically in 
activating solutions to 
elicit depolarization-
induced response
• Ca2+ uptake and leakage 
from the SR at different 
pH evaluated by bathing 
SMF in different pH 
solutions and depolarizing 
at normal pH
•↓ pH,  SR can not uptake 
Ca2+ as rapidly from 
myoplasm creating 
longer duration of 
depolarization-induced 
response
• Acidosis ↑ Ca2+ leak 
from SR and releases less 
calcium with 
depolarization






and Back White 
Skeletal
• Extracted SR vesicles 
placed in buffer solution 
at pH 7.1-6.5
• Ca2+ efflux measured via 
effluxing agent and  dual-
wavelength 
spectrophotometer
•  To measure [H]
Ryanodine binding,  SR 
membranes incubated in 
chemical medium, 
introduced to various 
channel-modifiers, placed 
in scintillation cocktail, 
shaken overnight, and 
analyzed
• Decreasing pH ↓ [H]
Ryanodine binding 
regardless of other 
experimental conditions
•  [La+] is strong inhibitor 
of [H]Ryanodine binding
Pate 1995 (78) Rabbit Psoas • Skinned SMF buffered to  
pH of 7.0 or 6.2
• SMF stimulated at either 
30°C (physiological 
condition) or 10°C
•  At 10°C in acidified 
condition, maximum 
velocity of shortening 
and isometric tension 
significantly ↓ 
•  At 30°C, maximum 
velocity of shortening 
slightly ↑ while 
isometric tension still ↓ 
while acidified
18









• Whole mouse extensor 
digitorum longus used 
to measure pH changes 
during stimulation and 
rabbit psoas SMF used 
to control proton 
concentration and 
manipulate temperature
•  Whole muscle and SMF 
bathed in normocapnic 
or hypercapnic solution, 
stimulated electrically at 
13 to 25°C
• Hypercapnia ↓ pH at 15 
and 25°C but force 
inhibition greater at lower 
temperatures in mouse 
muscle
• ↔ Temperature-
dependent inhibition of 
force in individual rabbit 
fibers at maximum Ca2+ 
activation
• Temperature affects 






• SMF perfused in Tyrode 
control, acidifying, or 
alkalanizing solution
• Muscles stimulated at 
either 12, 22, or 32°C 
(all below physiological 
temperature) 
• Fluorescent pH indicator 
SNARF-1 used to 
measure pH 
• In acidified fibers, force ↓ 
more at lower 
temperatures than at 32°C
• Acidification slowed 
relaxation but  mitigated 
by ↑ temperature
• Shortening velocity ↓ 
with acidification and low 




Rat Flexor Brevis • SMF perfused in 30% 
CO2 environment at 
28°C (acidified 
condition)
• SMF stimulated until 
force declined to 40% of 
control’s force 
production
• pH analyzed via 
fluorescent probe
• Intracellular acidification 
↔  tetanic force 
production or number of 
stimulations required to 
induce fatigue




 Mouse Flexor 
Brevis
• SMF perfused in 
solution designed to 
determine intensity 
dependence of pH and 
pH dependent 
mechanisms of fatigue
• Muscle stimulated at 
different intensities to 
induce fatigue
• Ca2+ release by SR ↑ 
with ↑ acidosis and 
fatigue
• Ca2+  sensitivity of 
contractile proteins ↓ 
with large acidosis
• Ca2+ release failure does 
not require nor is 
augmented by acidosis
19









• Extracted SR vesicles 
incorporated into lipid 
bilayer membrane to study 
Ryanodine (RyR) receptor 
Ca2+ release channels 
• pH altered and cytoplasmic 
and luminal pH studied in 
the pH range of 5-8
Acidic cytoplasmic pH ↓ 
RyR activity while luminal 




Rat Soleus • Whole muscle incubated in 
K+ solution and affixed to 
force transducer
• Muscles stimulated through 
motor nerve and analyzed 
for membrane potential, 
Ca2+ influx, Ca2+ content, 
Na+/K+ pump activity, and 
intracellular pH
• Lactic acid added to isolated 
muscle whose force had 
been depressed by elevated
   K+ 
• Addition of lactic acid 
recovered force more 
quickly and prevented 
reduction in force when 
introduced with 
   K+
• Acidification may be 
protective during high-
intensity exercise when 
extracellular K+ 




Rat Soleus • Isolated muscle placed in 
lactate, high K+, or 
bicarbonate-free medium 
and stimulated electrically
• Role of pH on K+ uptake 
rate observed
• Study performed in 
response to Nielsen et al. 
• Lactate and lactic acid 
incubation lead to force 
recovery in K+ depressed 
in vitro muscle
• In vivo mechanism is not 
as such and lactate/lactic 
acid is not protective
PFK = Phosphofructokinase, F-6-P = Fructose-6-Phosphate, G-6-P = Glucose 6 
Phosphate,  Mg2+ = Magnesium,  mM  = Millimole, Ca2+ = Calcium, Na+ = 
Sodium, K+ = Potassium, SR = Sarcoplasmic Reticulum, H+ = Hydrogen, Bx = 
Biopsy, PPO2 = Partial Pressure of Oxygen, PPCO2 = Partial Pressure of Carbon 
Dioxide, O2 = Oxygen, Hb = Hemoglobin, HCO3- = Bicarbonate, Hct = 
Hematocrit, ATP = Adenosine Triphophate, ADP = Adenosine Monophosphate, 
AMP = Adenosine Monophosphate, Lac = Lactate, CP = Creatine Phosphate,Gly 
= Glycogen, NADH = Nicotinamide Adenine Dinucleotide, PO4 = Phosphate, 
SMF = Single Muscle Fiber, F-1,6-DP = Fructose-1,6-Diphosphate, ↑ = Increase, 
↓ = Decrease, ↔ = No Change
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The Impact of pH and Lactate on Cycling, Leg Kicking, and Isometric 
Exercise in Man
 As early  as 1933 it was observed that a fatigued state coincided with lactic 
acid accumulation from muscular work in man (63).  Since then, the relationship 
between intensity and blood and skeletal muscle pH during high-intensity 
exercise, specifically cycling exercise, has been well documented (36, 38, 48, 53, 
83, 85).  When pH declines and lactate increases in working skeletal muscle and 
blood during heavy exercise, performance starts declining and fatigue ultimately 
forces retirement.
 Although the majority  of mechanistic research regarding pH and muscle 
function has been  performed with animals, a few studies have evaluated the 
effects of lowered pH on human muscle fibers in vitro.  For example, a reduction 
in pH is detrimental to glycolysis during exercise (46, 53), possibly by  inhibiting 
adenylcylase and phosphorylase b kinase (13) or glycogen phosphorylase (89), 
necessary  enzymes in the glycolytic cascade.  Messonier et al. showed that higher 
concentrations of MCT1 and MCT4, hydrogen transport proteins in skeletal 
muscle responsible for maintaining acid-base homeostasis, improves cycling 
performance, thus demonstration a clear link between pH regulation and fatigue 
(70).  However, Sahlin et al. reported that force recovers much more quickly than 
pH after exhausting leg exercise, implying that  pH is not the sole source of 
anaerobic muscle fatigue (84).
 As previously  detailed, lactate is created as a by-product of anaerobic 
glycolysis during intense exercise.  Even though lactate itself is a fuel and is not 
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considered a direct cause of muscle fatigue, measuring blood lactate serves as a 
good indicator of the myocellular environment during exercise.  Hydrogen ions 
are shuttled to the blood via the same carrier as lactate (MCT4) which makes 
lactate an indirect measure of pH.   Further, various studies collectively indicate 
that lactate is associated with fatigue during high-intensity  exercise (2, 9, 41, 50, 
97).  However, McCartney et al. documented a smaller lactate accumulation 
following exercise with induced acidosis (65).  Although it  should be emphasized 
that associations do not equal causality, the general relationship between muscle 
and blood lactate and pH and fatigue suggests that  changes in blood and muscle 
pH are likely two factors of many that contribute to fatigue during high-intensity 
exercise.
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Table 2.3: The Impact of pH and Lactate on Cycling, Leg Kicking, and 
Isometric Exercise in Man
Author/
Year






• Subjects ran at  
different intensities 
on different days





↑ exercise intensity,  






and 11 male 
subjects
• On bicycle 
ergometer or 
treadmill,  40-60 sec 
x 5 bouts, 4 minutes 
REC between
• BS and quadriceps  
Bx  post-exercise
BS and Bx 
analyzed for 
pH
Blood and muscle 







• Supramaximal VO2 
test on a cycle 
ergometer (T1)
• On separate day, 
subjects performed 
test again preceded 
by 5 minutes of 
heavy arm exercise 
to elevate blood 
  [La+] (T2)
• Exercise BS and EG




time was the 
performance 
criterion
• ↓ blood pH and ↑ 
peak lactate with 
T2
• ↔ Maximal 
aerobic power but 
tendency towards 
↓ endurance time






• 2 trials separated by 
5-7 days: 
Exhaustive leg 
cycling followed by 
exhaustive arm 
cycling and vice 
versa
• Deltoid and VL Bx 
immediately and 5 
min after exercise
• BS pre, during, and 
post exercise
• Exercise EG
• Bx analyzed 
for ATP, CP, 
pyruvate, 
and Lac
• TTE was 
performance 
criterion
• Performance ↓ in 
following bout of 
exercise after rest
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Table 2.3: The Impact of pH and Lactate on Cycling, Leg Kicking, and 
Isometric Exercise in Man (continued)
Author/
Year
Subjects Design Analyses Findings
Sahlin 1976 
(85)




• Subjects exercised 
until exhaustion or at 
a % of VO2max 
• VL Bx of 12 subjects 
post-exercise 
• Experiment 
conducted twice, one 
week apart
• Exercise BS
• BS analyzed 
for [La+] 
and pH
• Bx analyzed 
for pH
• Muscle pH ↓ 




to muscle [La+] 
and pyruvate 
content  













• Subjects performed 
isometric  quadriceps 
exercise or 6 minutes 
cycling 
• Medial quadriceps Bx 
of both groups at 
various time points







↓ linearly with 
  [La+]
• CP showed 
nonlinear 
relationship to 











3 hours, and cycled at 
33 and 66% VO2max 
for 20 minutes and 
rode to exhaustion at 
95% VO2max
• BS pre, during, and 
post exercise
• EG measured during 
exercise





  PPO2, 
PPCO2,





• [La+] and 
endurance time 
↑ with 
NaHCO3 and ↓ 
with NH4Cl
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Table 2.3: The Impact of pH and Lactate on Cycling, Leg Kicking, and 
Isometric Exercise in Man (continued)
Author/
Year






• Cycling at pace 
selected to cause 
fatigue within 6 
minutes 
• BS pre, during, and 
post exercise 
• Medial quadriceps 
Bx post exercise






• Bx analyzed for 
water, 
electrolytes, [La
+], and acid-labile 
CO2
• pH ↓ from 
7.00 to 6.4 
post exercise










9 males • 4 trials, 5 minutes 
maximal cycling at 
variable work rate 
(T1)












• 5 minutes maximal 
cycling (T2)
• Recovery BS
• BS analyzed for 
[La+]






levels but [La+] 






6 males • 3 trials: 17, 21, or 
60% O2 following 
equilibration 
period
• 10 minutes cycling 
at 55% VO2max 
and ride to 
exhaustion at 90%
• BS pre, during, and 
post exercise.
• EG pre and during 
exercise
• BS analyzed for 
PPO2, PPCO2,
   [La+], and pH








Table 2.3: The Impact of pH and Lactate on Cycling, Leg Kicking, and 
Isometric Exercise in Man (continued)
Author/
Year







• Experiment A:  
subjects’ leg was 
occluded for 50-60 s 
and Bx after 
adrenaline infusion
• Experiment B:  
   isometric 
contraction after leg 
occlusion and Bx 
after adrenaline 
infusion 















• Cyclic AMP and 
phosphorylase 
both ↓ in 
acidodic 
conditions









• 3 trials 1 week apart
• 5 minutes at 95% 
VO2max, 4 minute 
rest period, and ride 
to exhaustion at 
90% VO2max.  
• Trials differed by 
varying percent 
oxygen inhalation 
(16% O2, 21% O2, 
or 60% O2) during 5 
minutes exercise to 
elicit different blood 
[La+] levels
• Exercise BS and EG
• BS analyzed 
for [La+], pH 
and PCO2
• Total power 
output during 
the 5 minutes 











• H+ and [La+] ↔ 
at exhaustion
•  [La+] 
significantly ↑ 









• Isometric quadriceps 
contraction at 66% 
MVC until force 
declined







•  Endurance 
measured by timing 
initial contraction
• Bx after initial 
contraction












• ↔ force with 
low pH but 
endurance ↓












Table 2.3: The Impact of pH and Lactate on Cycling, Leg Kicking, and 
Isometric Exercise in Man (continued)
Author/
Year
Subjects Design Analyses Findings
Spriet 1989 
(89)
7 men and 
1 woman
• 3 30-second 
maximal 
isokinetic 
cycling bouts at 
100 rpm 
separated by 4 
minutes rest 
• VL Bx between 
bouts 2 and 3
• Bx analyzed for 











• Work in bout 3 ↓ 
to 82% of work 
from bout 2 while 
glycogenolysis in 
bout 3 was 32% of 

















exercise for 10 
minutes at 10 W
• 33 minutes rest 







•  Arm exercise 
used to elevate 
blood
  [La+] levels 
before 
exhaustive 
kicking exercise  




 > 55 rpm was 
performance 
criterion
• Blood flow 
measured via 
thermodilution and 




•  Bx analyzed for 
[La+], glycogen, 
and CP
• HL ↓ duration of 
exercise 




exercise in both 
conditions
• ↑ muscle H+ 
concentration after 
exercise in HL
•  Muscle fatigue 
occurred at ↓ pH 
but ↔ femoral 
blood K+ content 
in HL condition
• ↓ pH ↔ rates of 
glycogen 
breakdown or 
   [La+] production
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Table 2.3: The Impact of pH and Lactate on Cycling, Leg Kicking, and 
Isometric Exercise in Man (continued)
Author/
Year





• 3 30-second maximal 
cycling bouts, 4 
minute passive 
recovery between, 30 
minutes exercise at 
30-35% peak oxygen 
consumption and 60 
minutes rest prior to 
bout 4
• Bx pre-exercise and 
after third and fourth 
bouts,BS throughout
• BS analyzed for 
Hb 
concentration, 
Hct, plasma H+, 
[La+], and K+
• Bx analyzed for 
peak SR Ca2+ 
uptake, pH, and 
metabolites
Bout 3 and 4 
performance ↓ 
not result of ↓ 
muscle glycogen 
but ↓ CP 
availability, ↑ H+ 
concentration, or 








• Work Capacity Event:  
2 trials 3 days apart
•  Ingest sodium citrate 
(E) or lactose (C) and 
exercise at 120% 
Wmax until exhaustion
• BS post exercise 
• Standardized Event:  
Same as above except 
fixed-time so work 
rate and duration are 
controlled
•  VL Bx pre and post
•  BS post-exercise
• BS analyzed for 
[La+] and pH 
• Bx analyzed for 
























• Those who 
benefitted most 
in E condition 
were those with 
↑ content of 
pH/
  [La+] regulating 
proteins
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Table 2.3: The Impact of pH and Lactate on Cycling, Leg Kicking, and 
Isometric Exercise in Man (continued)
Author/Year Subjects Design Analyses Findings
Iaia 2010 (46) 7 healthy 
males
• Exhaustive cycle 
exercise preceded 
by a warm-up, very 
high (30 seconds), 
high (3 minutes), 
and low (2 hours) 
intensity cycling
• Post 2 minutes 
recovery, subjects 
rode to exhaustion 
at 130% VO2max 
• BS pre, during, and 
post exercise
• VL Bx before and 
after both 
exhaustive bouts





• Bx analyzed 




glycogen and pH 
do not control 







less than 2 
minutes
s = Seconds, REC = Recovery, BS = Blood Sample, Bx = Biopsy, EG = Expired 
Gasses, VL = Vastus Lateralis, [La+] = Lactate concentration, ATP = Adenosine 
Triphophate, ADP = Adenosine Monophosphate, AMP = Adenosine 
Monophosphate, CP = Creatine Phosphate, HCO3 = Bicarbonate, F-6-P = 
Fructose-6-Phosphate, G-6-P = Glucose-6-Phosphate, G-1-P = Glucose-6-
Phosphate, H+ = Hydrogen, MVC = Maximal Voluntary Contraction, F-1,6-P2 = 
Fructose-1,6-Biphosphate, Glyc-3-P = Glycerol-3-Phosphate, K+ = Postassium 
HR = Heart Rate, MCT1 = Monocarboxylate Transporter 1, MCT4 = 
Monocoarboxylate Transporter 4, NHE1 = Na/H+ Exchanger 1, FFA = Free Fatty 
Acid, 2,3-DPG = 2,3-Diphosphoglycerate, TTE = Time to Exhaustion, ↑ = 
Increase, ↓ = Decrease, ↔ = No Change
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Sodium Bicarbonate/Citrate Supplementation and Cycling Performance
 The independent effects of sodium bicarbonate and citrate 
supplementation on cycling exercise of various durations and intensities are well-
documented.  A number of studies have shown that both bicarbonate and citrate 
improve performance during high-intensity, short duration, interval type cycling 
(11, 18, 47, 60, 62, 66, 67, 69, 77), aerobic cycling (≥ 30 minutes) (68, 72, 92), 
and intermittent cycling (81).   However, the literature is not unanimous as others 
have shown no benefits of supplementation during high-intensity (44, 51, 54, 94, 
99) and long-duration cycling (86, 91).  
 Bicarbonate is a prominent extracellular buffer in the blood and ingesting 
either sodium bicarbonate or citrate elevates blood bicarbonate levels.  Bishop  et 
al. suggests that improved performance with bicarbonate supplementation is likely 
the result of increased extracellular buffering causing greater efflux of hydrogen 
from muscle to blood (11).  Since intracellular hydrogen is suspected to play a 
role in muscle fatigue, this efflux of hydrogen would be beneficial during intense 
anaerobic exercise.  McNaughton et al. also illustrated that sodium bicarbonate 
supplementation during intense aerobic cycling of one hour yielded a performance 
benefit, citing an alteration in extracellular buffering capacity similar to Bishop et 
al.’s postulation (68).  Despite its impact on blood and muscle pH (18, 86, 91, 99), 
blood and muscle lactate (42, 92), as well as performance (11, 47, 60, 66, 67, 72, 
77), bicarbonate is not generally  used as an ergogenic aid because of gastric 
discomfort often resulting in urgent diarrhea (35, 91) or possible lightheadedness 
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(54).  However, the fact that cycling performance is improved by altering blood 
and muscle pH via artificial augmentation of buffering capacity provides 
compelling evidence that pH has a role in muscular fatigue during heavy exercise.
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• Cycle for 20 minutes 
at 33% VO2max, 20 
minutes at 66% 
VO2max, then 95% 
VO2max to 
exhaustion




• Endurance longest 
in alkalotic 
condition and 
shortest in acidotic 
condition
• [La+] ↑ most from 
rest to exhaustion 
with alkalosis and 
least with acidosis
• Plasma [La+] least 
with acidosis 
implying inhibition 
of glycolysis and ↓ 
   [La+] efflux
Inbar 
1983 (47)
13 males • 2 Trials: 10 grams 
NaHCO3 or placebo
• 6 minutes cycling, 
4-6 second sprints at 
400 watts every 2 
minutes, 30 seconds 
all-out at 4.41 J/
pedal revolution/kg
• BS pre and post 
exercise
•  VL Bx pre-exercise
• BS analyzed 
for pH and [La
+], fiber type





• Mean power output 
significantly ↑ with 
NaHCO3  
•  ↔ Peak power 
output
•  No relationship 





2 men and 
1 woman
• NaHCO3 (E) or NaCl 
(C) an hour before 
cycling
• 4 1-minute bouts, 
ride to exhaustion at 
100% VO2max
• BS and EG 
throughout exercise 
and recovery
• BL Bx before 
ingestion, first bout, 
and final bout
• BS analyzed 
for lactic acid, 
pH, PCO2, and 
blood HCO3
• Bx analyzed 
for lactic acid 
and pH 




• During and 
following exercise, 
blood pH and HCO3 
↑ with E 
• NaHCO3 ↑ 
Performance
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Table 2.4:  Bicarbonate/Citrate Supplementation and Cycling Performance 
(continued)




Katz 1984 (51) 8 males • 3 trials: 0.2 g/kg 
NaHCO3 or 
placebo
• Ride to 
exhaustion at 
125% VO2max
• BS pre, during, 
and post exercise
•  Recovery EG
• BS analyzed 
for [La+], pH, 
and pCO2
• TTE was the 
performance 
criterion
• [La+] efflux ↑ 
with bicarbonate 
ingestion  










• 4 conditions: 
Injection of 
either 0.18, 0.36 
g/kg NaHCO3 or 
placebo
• 4 1-minute bouts 
at 125% VO2max 
separated by 1 
minute rest and a 
fifth bout to 
exhaustion
• BS pre, during, 
and post exercise
• Exercise EG
• BS analyzed 
for pH, base 
excess, HCO3, 
and [La+] 
• TTE was 
performance 
criterion









6 males • 3 Conditions: 
placebo, 0.15, or 
0.30 g/kg of 
NaHCO3
• 5 bouts of 60 
seconds at 125% 
VO2max and a 
sixth bout to 
exhaustion
• BS  pre exercise 
• BS analyzed 




and TTE were 
performance 
criterion
• Work in kJ and 
TTE significantly 
↑ in both 
NaHCO3 
conditions  













• 3 30 s Wingate 
tests separated 
by 6 min 
recovery
• BS pre, during, 
post exercise
• BS analyzed 
for pH, [La+], 
and PPCO2











Table 2.4:  Bicarbonate/Citrate Supplementation and Cycling Performance 
(continued)









• 4 Trials: 
placebo, 0.10 , 
0.15, or 0.20 g/
kg of NaHCO3 
• Cycle sprint for 
2 minutes
• BS pre and post 
ingestion, post 
exercise
• BS analyzed for 
lactic acid, pH, 
PCO2, and PO2 





• ↑ in post blood 
bicarbonate 
related to dosing
• This dosing 
scheme yielded 
↔ performance 







• 6 trials:  3 
placebo and 3 
300 mg/kg 
NaHCO3











• NaHCO3 ↑ 
average power 
and peak power 
output 
• Difference in 










• Ride to 
exhaustion at 
80% VO2max 
• Exercise BS 
and EG
• BS analyzed for 





• TTE was 
performance 
criterion
• Endurance ↑ 
with  HCO3
• Plasma glucose ↑ 
at exhaustion in 
control and [La+] 
↑ in HCO3 
condition 
• Performance ↑ 











• One minute all-
out sprint on a 
bicycle 
ergometer
• BS pre and post




• Work performed 
in the minute 








• Post-exercise Lac 
↑  with 
bicarbonate
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• 3 trials: control, 
placebo, or NaHCO3 
• 10, 30, 120, or 240 
seconds of all-out 
cycling 
• BS pre and post
• BS analyzed for 
PPO2, pH, 
HCO3 , and 
  [La+]
• Total amount of 
work and peak 
power were the 
performance 
criterion
• NaHCO3 ↑ 




10 or 30 s













• 2 conditions: 
placebo or 300 mg/
kg of NaHCO3 
• 1 minute intervals at 
95% VO2max until 
exhaustion
• BS pre, during, and 
post exercise 
• Exercise EG
























• 3 trials:  3 minutes of 
cycling at VO2max, 
VO2max + 17%, or 
VO2max + 17% and 
ingestion of 400 mg/
kg of NaHCO3
• Functional electrical 
stimulation test pre 
and post exercise to 
determine 
  quadriceps fatigue
• Exercise EG
Peak torque was 
performance 
criterion

















women and 5 
men
• 5 trials: VO2peak 
test, 2 exhausting 
rides at 120% 
VO2peak after 
sodium citrate or 
placebo ingestion, 
2 trials at same 
relative intensity 
as previous trials 
minus 20 seconds
• BS throughout all 
trials and VL Bx 
before 4th and 5th 
trials
• BS analyzed for 
pH and [La+] 
• Bx analyzed for 
CP, ATP, G-6-P, 
[La+], and 
citrate




ingestion ↑ TTE 
during 
supramaximal 









• 3 trials: control, 
placebo, or 
NaHCO3 
•  60 minutes 
cycling
• BS pre, during and 
post exercise  








ratio were the 
performance 
criterion
• Amount of 











• 2 trials separated 
by 2-3 weeks:  0.3 
g/kg of NaHCO3 
or placebo
• 15 minutes at 30, 
60, and 75% 
VO2max
• BS and EG 
throughout 




• 5 VL Bx at rest, 
post-ingestion, 
and 3 during 
exercise















G-1-P, F-6-P, and 
Gly-3-P.  BS 

















• ↑ [La+] 
production
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• 4 trials 3-7 
days apart: 40 








kg, 0.4 g/kg, 
0.6 g/kg)
• Exercise BS











Despite influencing blood 
pH, no dosage of sodium 
citrate improved time trial 
performance, sprint 








• 2 trials: 0.3 g/
kg NaHCO3 or 
placebo   
• 30 minutes 




~30 min at 
~80% 
VO2peak
• BS pre, during, 
and post 
exercise
• Bx pre and 
post
• BS analyzed 
for pH, gas 
partial 
pressure, [La
+], Na, K+, and 
Cl
• Bx analyzed for  
glycogen, [La








• NaHCO3 caused small 
but significant ↓ in 
muscle pH maintained 
through exercise
•  Induced metabolic 
alkalosis ↔ prolonged 
cycling performance




accumulation, or CP 
degradation 
• 2 subject defecated 












minute blocks:  
90 s at 40% 
VO2max, 60 s 
at 60% 
VO2max, 14 s 
maximal 
sprint, and 16 s 
rest for 30 
minutes
• BS pre, during, 
and post 
exercise
• BS analyzed 
for   pH and 
HCO3 









criterion   
• ↔ Peak power output 
between trials, fatigue 
index significantly 
different between trials, 
and ↑ peak power 
output with NaHCO3
• Blood HCO3 
concentration ↑ post 
exercise with NaHCO3 
and pH remained higher 
throughout exercise
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• 2 trials: NaHCO3
  or placebo
• 5 x 6 s all-out 
sprints every 30 s
• BS and EG 
throughout 
protocol 
• Quadriceps Bx 
pre and post
• BS analyzed for 
[La+] and pH  
• Bx analyzed for 
[La+], pH, and 
buffering 
capacity
• 95% of first 6 








• NaHCO3 ↑ total 
work and ↑ 
work and power 
in sprints 3, 4, 
and 5 
• ↔ post-test 





•  ↑ Performance 









7 healthy men • 2 trials: placebo 
or 3 mmol/kg of 
NaHCO3
• Cycling at 40 or 
87% VO2max for 
6 minutes 
separated by 20 
minutes rest
• BS pre, during, 
and post exercise
•   Exercise EG
BS analyzed for 
[La+], pH, HCO3, 
blood gasses, Na, 





VO2 kinetics not 
altered by 
NaHCO3 at low 
intensity (40% 
VO2max) but was 
at high intensity 
(87%)
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Table 2.4:  Bicarbonate/Citrate Supplementation and Cycling Performance 
(continued)








• 2 trials: 0.3 g/
kg of NaHCO3 
or placebo 










• BS pre, during, 
and post 
exercise
• BS analyzed for 
[La+] changes 
• Change in critical 
power, or the 
boundary between 
heavy and severe 
exercise associated 
with maximal [La
+] steady state, 
and the curvature 
constant of power 





• NaHCO3 ↔ 















BS = Blood Sample, EG = Expired Gasses, Bx = Muscle Biopsy, [La+] = Lactate 
NH4CL = Ammonium Chloride, NaHCO3 = Sodium Bicarbonate, HCO3 = 
Bicarbonate, K+ = Potassium, Na = Sodium, CP = Creatine Phosphate, H+ = 
Hydrogen, CL = Chloride, ATP = Adenosine Triphopshate, Hb = Hemoglobin, Hct 
= Hematocrit, VL = Vastus Lateralis, TTE = Time to Exhaustion, CaCO3 = 
Calcium Bicarbonate, PPO2 = Partial Pressure of Oxygen, PPCO2 = Partial 
Pressure of Carbon Dioxide, s = Seconds, ↑ = Increase, ↓ = Decrease, ↔ = No 
Change
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Herbal Supplementation, Cycling Performance and Muscle Fatigue
 Herbal supplementation to improve exercise performance has become a 
popular alternative to bicarbonate and citrate since there are generally less 
gastrointestinal ramifications.  The supplement being tested in this study, 
SR2W-1, consists of a proprietary blend of the following herbal ingredients: 
enoki mushroom, eleuthero extract (Eleutherococcus senticosus), reishi 
mushroom, tangerine extract, cordyceps mushroom (Cordyceps sinensis), and 
asian ginseng (Panax ginseng).  The efficacy of SR2W-1 was evaluated on one 
other occasion in cyclists and the results indicated that the supplement decreased 
lactic acid accumulation, increased pH, and increased blood bicarbonate during 
recovery from intense exercise.  However, time to complete a 60,000 Joule time 
trial was not affected (57).  No other supplement contains the combined 
ingredients in SR2W-1, but some of the individual constituents of the proprietary 
blend have been evaluated for potential ergogenic effects during cycling, namely 
Eleutherococcus senticosus (eleuthero extract),  Cordyceps sinensis (cordyceps 
mushroom), and Panax ginseng (asian ginseng).
 Two studies evaluating Eleutherococcus senticosus in cyclists have shown 
improved performance.  Asano et al. found that supplementation with eleuthero 
extract improved VO2max and time to exhaustion.  However, glaring limitations in 
the experimental design make it difficult to interpret  these findings, consequently 
limiting generalizability (7). Kuo et al. found similar results to Asano’s study 
utilizing a cycling protocol at 75% VO2peak.   The authors also observed elevated 
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free fatty acid levels with supplementation (56).  In contrast,  Eschbach et al. 
found that  eleuthero supplementation failed to confer any  performance or 
metabolic advantages during endurance cycling (29).  It is important to note that 
the loading period of Eschbach’s study was only one week as compared to eight 
weeks in Kuo’s study.
 Cordyceps sinensis (cordyceps mushroom) is another herb that has 
garnered attention as an ergogenic aid for cyclists.  The primary  claim regarding 
cordyceps sinensis is that  it  improves muscle oxygenation in mice and potentially 
in humans.  However, the three studies evaluating cordyceps usage in cyclists all 
failed to yield gains in performance or any metabolic parameters (15, 23, 76).  
 A third and most popularly  tested constituent of SR2W-1 is asian (panax) 
ginseng.  While studies involving other modes of exercise have yielded positive 
performance results with ginseng supplementation, asian ginseng does not appear 
to elicit similar results among cyclists (3, 25-27).  Although research involving 
elements of SR2W-1 and cycling performance have not been convincing, existing 
SR2W-1 research reveals that the combined and synergistic effects of the various 
herbals could potentially improve performance.
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6 males • 4 trials: 2 VO2max 
tests on consecutive 
days was control 
• 8 days placebo 
supplementation 
and VO2max test 









• ES ↑ VO2max 
compared to control 
but not placebo.  
ES ↑ TTE in all 
instances 
• Protocol is single-









• 8 mg/kg Panax 
Ginseng (PG) and 
placebo or 16 mg/
kg and placebo for 
seven days
• Ride to exhaustion 
at 75% VO2max
• BS pre, during, and 
post exercise
• Exercise EG 




• TTE was 
performance 
criterion






• R, DB, PC
• Placebo, 200 mg/
day, or 400 mg/day 
PG over 8 week 
period
• Graded cycling test 
starting at 100 watts 
and increasing 50 
watts every 3 
minutes to 
exhaustion
• Exercise EG 
• BS pre, during, and 
post exercise
• BS analyzed 
for [La+]
• VO2, RER, 
VE, HR, and 
RPE were 
recorded


















• 200 mg PG or placebo 
for 3 weeks




• BS analyzed 
for [La+]  













• DB, between-groups 
design
• Subjects paired based on 
[La+] threshold and 
assigned to supplement 
with 950 mg/day of 
herbal formulation 
(SR2W-1) or placebo for 
5 weeks
• Cycle at [La+] threshold 
for 20 minutes, rest for 
12 minutes, then 
complete 60,000 J   TT
• BS pre and post exercise







• SR2W-1 ↓ 
lactic acid 
accumulation, 
↑ pH, and 
smaller drop in 
HCO3 during 
recovery









• DB, R, XO
• 1200 mg/day of ES or 
placebo for 7 days
• 120 minutes at 60% 
VO2max followed by 10 
km TT
•  BS every 20 minutes 
during steady state 
exercise
• Exercise EG
• BS analyzed 
for [La+] and 
glucose
• TT 













• 400 mg of PG or placebo 
for 8 weeks
• 30-second Wingate 
cycling test




















• 2 trials:  3 ml/kg of 
placebo or Argomas 
herbal supplement
• Cycle to exhaustion at 
70% VO2max for 90 
minutes then 80% 
VO2max to exhaustion
• Exercise EG 
TTE was the 
performance 
criterion









• Pre and post 14 day 
loading period with 
Optygen (primarily 
cordyceps sinensis and 
rhodiola rosea)
• 4 minute stages starting 
at 100 watts, increasing 
25 watts until exhaustion
• Exercise EG
• BS pre, during, and post 
exercise
• BS analyzed 
for [La+]














• 5 weeks of 3.15 g of 
CordyMax Cs-4 
(cordyceps sinensis) or 
placebo
• 1-hour TT at 75% max 
wattage calculated from 
pre-test
• EG during and after 
exercise
TT completion 











• DB, R, PC
• 2000 and 1000 mg 
cordyceps sinensis and 
rhodiola rosea for 6 days 
and seven days 
respectively or placebo
• Graded test to  
exhaustion
• Exercise EG
• Muscle tissue 
oxygenation and blood 



















9 males • DB, R, XO
• 800 mg/day of 
ES and placebo 




• Cycling at 75% 
VO2max until 
exhaustion















• TTE was 
performance 
criterion






• 3 trials: water, 
rice flour 
(placebo), or 







• BS pre, during, 
and post 
exercise
• Total body 
water assessed 
pre and post 
exercise
• BS analyzed for 
[La+]
• VO2peak test 
served as the 
performance 
criterion
• ↔ aerobic exercise 
performance or
   [La+] response
• MAC ↑ total body 
water and 
intracellular water
ES = Eleutherococcus Senticosus, PG = Panax Ginseng, BS = Blood Sample, EG 
= Expired Gasses, TTE = Time to Exhaustion, Lac = Lactate, FFA = Free Fatty 
Acid, RER = Respiratory Exchange Ration, VE = Ventilation, HR = Heart Rate, 
RPE = Rate of Perceived Exertion, DB = Double-Blind Design, R = Randomized 
Design, PC = Placebo-Controlled Design, XO = Cross-Over Design, HCO3 = 
Bicarbonate, TT = Time Trial, CS = Cordyceps Sinensis
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Summary
 Much attention has been paid to the possible role that acidosis has in 
muscular fatigue during high-intensity exercise.  Proposed mechanisms include 
inhibited calcium release and uptake by the sarcoplasmic reticulum, inhibitions in 
calcium binding to troponin C, and functional disruptions of enzymes found in the 
glycolytic pathway, all of which could inhibit skeletal muscle function.  There is 
also evidence that lactate itself could influence calcium dynamics of the 
sarcoplasmic reticulum despite lactate being a potential source of fuel during 
exercise.  At the very  least, it is agreed that hydrogen ions and lactate accumulate 
during high-intensity exercise and that exercise intensity  cannot be maintained for 
an extended duration under these conditions.  Supplementing with sodium 
bicarbonate and citrate, compounds known to improve buffering capacity directly 
in the blood and indirectly in the muscle, improves performance and provides 
convincing evidence for the fact that pH management is important for preventing 
fatigue. Concentration of the pH/lactate management proteins MCT1 and MCT4 
substantiates this since possessing higher levels correlates to improved high-
intensity exercise performance.  Since bicarbonate/citrate supplementation often 
causes gastrointestinal problems, herbal supplementation has become popular as 
an alternative for altering pH during intense exercise.  The current  project was 
therefore designed to address the efficacy of a multi-ingredient herbal supplement 





 Seven male and female recreational cyclists, aged 18-55 were recruited 
from James Madison University and the surrounding Harrisonburg area.  Subject 
characteristics are summarized in Table 3.1.  Subjects were provided with written 
and verbal information about the experimental procedures, including potential 
risks, prior to completing the informed consent (Appendix II).  All procedures 
were approved by the James Madison University Institutional Review Board prior 
to testing.






























 Subjects performed a graded exercise test to determine peak oxygen 
uptake (VO₂max) on a Racermate Velotron (Seattle, WA) cycle ergometer.  Initial 
workload was subjectively determined during a self-selected 5-minute warm-up. 
Subjects selected an intensity maintainable for 90 minutes at an “easy to 
moderate intensity.”  Following the warm-up, workload was incrementally 
increased by 20 W every 3 minutes until volitional fatigue or until subjects could 
no longer maintain a pedaling cadence ≥ 50 revolutions per minute.  VO2, RER, 
and VE were continuously  monitored with a Sensormedics Spectra metabolic cart 
(Yorba Linda, CA).  Heart rate throughout each test was monitored using a Polar 
heart rate monitor (Lake Success, NY).  Blood lactate levels were assessed via 
finger stick in the final minute of each exercise stage using a YSI 2300 STAT 
glucose/lactate analyzer (Yellow Springs, OH) to determine lactate threshold (≥ 1 
mmol/L above resting lactate levels), after which blood sampling was 
discontinued.  RPE was obtained in the final minute of each exercise stage and the 
workload (watts) at max was used to determine workloads during the 
familiarization and treatment trials.
Familiarization and Treatment Trials
 Each subject performed five trials over the course of nine weeks.  The 
initial trial was included as a familiarization session with four subsequent trials 
serving as the treatment trials (TT).  The general study design is outlined in 
Figure 3.1.  The four treatment trials were conducted using a randomized, double-
blind, cross-over design.   The first two treatment trials occurred before and after 
three weeks of supplementation with either placebo or SR2W-1.  Following a 14-
day washout phase, subjects completed two more treatment trials conducted 
before and after three weeks of supplementation (placebo or SR2W-1, depending 
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on first phase).  All trials were performed at ambient temperatures of 21-22°C. 
An Essential Home fan, set on ‘medium’ speed, was placed 2 meters from the 
handlebars of the cycle ergometer for cooling purposes during trials.  Subjects 
were instructed to perform each trial as a competitive event.
Figure 3.1: Study Design
 A visual representation of the exercise protocol is displayed in Figure 3.2. 
Subjects reported to the lab in the morning after a 10-12 hour overnight fast.  To 
standardize for postural-related hemodynamics, subjects laid down for ten 
minutes prior to blood flow measurements.  During that time, an indwelling 
catheter was inserted into the arm while their right leg was prepped for the muscle 
biopsy (Lidocaine, incision, and bandaging). Resting blood flow was then 
assessed by  the same investigator using a Shenzen Mindray DC-6  5-10 MHz 
duplex ultrasound machine (Shenzen, Nanshan, China).  
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Figure 3.2: Treatment Trial Protocol
 Following catheter insertion, biopsy preparation, and femoral ultrasound, 
subjects performed a 3-minute warm-up at 100 watts, after which the subjects 
rode for 20 minutes at a fixed-wattage that elicited 85% of the subject’s VO2max. 
Immediately  following the 20-minute ride, subjects completed three one-minute 
intervals at a workload coinciding with VO2max with 30-seconds of active 
recovery at 100 watts between each interval.  Following the final interval, subjects 
stopped cycling and began a 15-minute passive recovery phase during which the 
subject underwent a muscle biopsy (1 minute into recovery) and femoral artery 
ultrasound (8 minutes into recovery).  Following recovery, subjects cycled at a 
workload coinciding with VO2max until fatigued (cadence ≥ 50 RPM).
Exercise Performance
 Performance was measured by cycling duration (seconds) during the time 
to fatigue portion of the treatment trial.
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Muscle Biopsy
 Muscle biopsies were obtained from the vastus lateralis (VL) during the 
15-minute recovery  period of all treatment trials (10).  The biopsy was taken 
within 1 minute of dismounting the ergometer in order to capture the metabolic 
state of muscle immediately after exercise.  The muscle sample was quickly 
trimmed of excess adipose tissue and frozen in liquid nitrogen in order to halt 
metabolism.  Each sample was then stored at -80℃ for later analysis of muscle 
lactate.  The subjects were re-bandaged in order to complete the ride to 
exhaustion.
Muscle Lactate
 Muscle samples from each treatment trial were thawed to -20 to -15℃ and 
cut into 15-30 mg pieces using a refrigerated scale.  Samples were then refrozen 
at -80℃, transferred to a glass culture tube containing 0.5 ml 3 M perchloric acid 
(PCA) solution, homogenized, diluted with 1 M glycine/hydrazine stock (pH 9.8 - 
10), and stirred with a pestle.  NADH was then measured using a 
spectrophotometer at 340 nm. Muscle lactate values were calculated 
mathematically based on fluorescence results (17).
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Blood Lactate, pH, and Glucose
 Preceding each exercise trial, an indwelling antecubital venous catheter 
was inserted by a phlebotomy-trained investigator.  During exercise, the catheter 
was flushed periodically  with an injectible saline solution to prevent coagulation. 
Blood samples were obtained at the following time points: minutes 10 and 20 
during the 20-minute fixed intensity ride, after the second high-intensity  interval, 
and minutes 1.5, 3, 6, 9, 12, and 15 of recovery.  Glucose and lactate levels were 
measured immediately  from whole blood using a YSI 2300 STAT glucose/lactate 
analyzer (Yellow Springs, Ohio).
VO2, RER, and Ventilation
 VO2, RER, and Ventilation were assessed at minutes 10 and 20 during the 
fixed-intensity ride and after the second high-intensity interval.  A SensorMedics 
Spectra (Yorba Linda, CA) metabolic cart  was used to monitor breath-by-breath 
gas exchange and average respiratory data over thirty seconds.
Heart Rate
 Heart rate was recorded at minutes 10 and 20 during the fixed intensity 
ride, after the second high-intensity  interval, and at minutes 3, 6, 9, and 12 during 
the recovery phase using a Polar heart rate monitor (Lake Success, NY).
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Ratings of Perceived Exertion (RPE)
 Subjective ratings of exertion were obtained by  having the subject point to 
a corresponding exertion level on a Borg RPE scale (numerically rated from 
6-20).  RPE was obtained at minutes 10 and 20 of the fixed intensity ride and after 
the second high-intensity interval.
Blood Flow
 Left femoral artery peak velocity  and diameter were measured 5-7 mm 
below the inguinal crease using a Mindray  DC-6 (Nanshan, Shenzen, China) 5-10 
MHz duplex ultrasound machine.  Blood flow was calculated using the equation: 
∏r² (mm) x peak velocity (cm/s) x 60 seconds.  Pre-exercise peak velocity and 
diameter was assessed at rest and post-exercise measurements were obtained eight 
minutes following the completion of the high-intensity intervals.
Supplement
 Subjects were randomly assigned to receive either 1000 mg/day  of 
SR2W-1 or 1000 mg/day of placebo.  Subjects ingested 2 x 500 mg capsules 
every  morning for 21 days during the supplementation periods.  To promote 
supplementation compliance, subjects were required to text, e-mail, or call a 
member of the investigative team immediately after supplementation.  SR2W-1 is 
a proprietary  blend of herbs and fungi (primary ingredients: Enoki mushroom, 
Eleuthero extract, Reishi mushroom, tangerine extract, Cordyceps mushroom, and 
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Asian Ginseng).  The placebo was provided by Radix BioResearch and was in 
capsule form identical to SR2W-1.
Dietary and Exercise Controls
 Throughout the duration of the study, subjects were instructed to: 1. 
maintain consistent dietary habits for 72 hours prior to each trial, 2.  complete a 
diet record (Appendix V) for the 24 hours preceding each trial, 3.  avoid heavy 
exercise for 48 hours prior to each trial, 4. maintain consistent physical activity 
habits starting 72 hours prior to the first treatment trial until the completion of the 
final treatment trial (~55 days), and 5.  Record all physical activity performed 
during the 24 hours preceding each trial (Appendix VI).  Subjects consumed their 
final ‘self-selected’ meal no less than 10 hours prior to the start of treatment trials 
(i.e. dinner on the evening prior to testing) and were allowed to consume only 
water ad libitum until the end of each treatment trial (total of ~10-12 hours of 
fasting with water intake).
Statistical Analyses
 Due to the small sample size in this study, the Wilcoxon Signed Rank test 
was applied to compare change scores from pre- to post- supplementation (EXP 
vs. PLA for each dependent variable).  More specifically, differences between pre- 
and post-supplementation cycling time to fatigue, muscle lactate, blood lactate, 
blood glucose, VO2, RER, VE, HR, and skeletal muscle blood flow were 
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compared between treatments at a given time point during exercise and recovery. 
Significance was set at  p < 0.05.  All blood lactate data during recovery was 
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ABSTRACT 
Purpose: The purpose of this investigation was to examine the effects of SR2W-1 
herbal supplementation on cycling performance, muscle and blood lactate, and 
various physiological parameters including blood glucose, heart rate (HR), rating 
of perceived exertion (RPE), oxygen consumption (VO2), expired ventilation 
(VE), respiratory exchange ratio (RER), and femoral artery blood flow. Methods: 
Seven recreational cyclists (Age: 26.7 ± 9.8 yrs, Height: 172.5 ± 13.3 cm, Weight:
67.1 ± 10.7 kg, and VO2max: 59.5 ± 11 mL/kg/min) performed 20-min of steady-
state cycling (~85% VO2max, 212.1 ± 25.0 W) followed by three 1-min high 
intensity intervals at VO2max workload (272.9 ± 26.9) with 30-sec active recovery 
periods at 100 watts.  Following intervals, a 15-min passive recovery period 
preceded a ride to fatigue at VO2max workload. Subjects completed trials on four 
occasions; preceding and following 21 days of 1000mg/d SR2W-1 (EXP) and 
1000mg/d placebo (PLA) assigned in random order.  The Wilcoxon Signed-Rank 
Test was used to compare change-scores from pre- to post- PLA and EXP 
conditions.  Results: No differences reported for any dependent variable and 
performance times were not different between PLA  (pre-PLA: 180 ± 48 s;  post-
PLA: 198 ± 56 s) and EXP (pre-EXP: 170 ± 57 s; post-EXP: 191 ± 50 s). 
Conclusion: Notwithstanding the small sample size, 3 weeks of SR2W-1 
supplementation does not appear to aid cycling performance, attenuate skeletal 
muscle fatigue, or modify general physiological responses to exercise. 
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INTRODUCTION
 High levels of blood lactate and concomitant reductions in pH are strongly 
associated with the onset of fatigue.  In 1907, Fletcher and Hopkins examined 
lactic acid levels in working frog muscles and stated that “an acid reaction of the 
muscle is, as most agree, a constant mark of the fatigued condition and a constant 
condition of the state of rigor,” providing evidence that acidity has been 
associated with decreased function and fatigue for over a century (33).   The 
precise role that lactic acid plays in muscular fatigue has been debated, partially 
as a result of the lack of supporting evidence regarding lactic acid’s proton 
contribution and the positive energetic properties of lactate.  However, the 
deleterious effects that hydrogen ions have on skeletal muscle function are well-
documented.  In-vitro skeletal muscle experiments have shown that low intra-
muscular pH can interfere with several reactions within the muscle cell, inhibiting 
function and causing fatigue (13, 30, 59).  It has also been suggested that 
hydrogen ion accumulation may inhibit the release of calcium from the 
sarcoplasmic reticulum and interfere with the transmission of neural impulses 
which can also decrease function (45).  Although there are other potential sources 
of muscular fatigue such as fatigue of the central nervous system, psychological 
factors, and inorganic phosphate accumulation in the muscle cell, acidosis is often 
regarded as the most prevalent source of fatigue during intense exercise.
 Since intense exercise is associated with a drop  in pH and inevitable 
fatigue, athletes can benefit from strategies that mitigate the acidifying effect of 
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exercise to enhance their performance.   In 1924, A.V. Hill acknowledged the 
importance of tissue and blood buffers and their effect on muscular effort (39). 
As early as the 1930’s, researchers experimented with induced alkalosis and its 
effect on performance.  They hypothesized that by increasing blood alkalinity, 
more lactic acid could be produced implying more energy  from anaerobic 
glycolysis and achievement of higher intensities (64).  After being largely ignored 
for nearly 30 years due to initial null findings, a resurgence of research in the 
1970‘s began to indicate that manipulating extracellular buffering capacity can 
impact intracellular pH.  Bicarbonate supplementation became the predominant 
mode of inducing blood alkalinity since the bicarbonate buffer system is a 
primary source of blood’s buffering capacity.   Research shows that increasing 
blood pH with bicarbonate increases the rate of lactate and hydrogen efflux from 
muscle cells despite the relative impermeability of the sarcolemma to bicarbonate 
(18, 43, 48, 88, 92).  This suggests that hydrogen ion efflux from the cell works 
down a concentration gradient.  Conceptually, an increased concentration gradient 
facilitated by changes in extracellular lactate/H+ should allow for more lactate/H+ 
transport from the active skeletal muscle, thereby delaying fatigue.  As a result, 
lactate/H+ supplement research has become prevalent due to its potential 
performance-enhancing benefits.                       
 SR2W-1 is a commercially  available herbal supplement designed to 
improve high-intensity exercise performance.  Preliminary research on the 
efficacy of SR2W-1 is promising as two investigations have demonstrated that 
60
SR2W-1 prolongs exercise endurance, promotes lactate clearance after 
exhaustive exercise, and improves overall performance (1, 57).  Additionally, 
some research involving the constituents of SR2W-1 have yielded performance 
benefits during cycling (7, 56).  However,  the two existing SR2W-1 studies were 
not peer reviewed and possessed major methodological limitations.    Thus, the 
primary aims of the current study were to evaluate the effect of the herbal 
supplement SR2W-1 on high-intensity cycling performance as well as blood and 
skeletal muscle lactate metabolism. Blood glucose, VO2, RER, VE, HR, RPE, and 
femoral artery blood flow were also observed to further elucidate the effects of the 
supplement.  We hypothesized that SR2W-1 supplementation would improve 
cycling performance, reduce blood lactate levels during varying intensities of 
cycling exercise and during exercise recovery, reduce skeletal muscle lactate 
levels, and increase blood flow during recovery.  
METHODS
Subjects
 Seven male and female recreational cyclists, aged 18-55 were recruited 
from James Madison University and the surrounding Harrisonburg area.  Subject 
characteristics are summarized in Table 3.1.  Subjects were provided with written 
and verbal information about the experimental procedures, including potential 
risks, prior to completing the informed consent (Appendix II).  All procedures 
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were approved by the James Madison University Institutional Review Board prior 
to testing.






























 Subjects performed a graded exercise test to determine peak oxygen 
uptake (VO₂max) on a Velotron Racermate (Seattle, WA) cycle ergometer.  Initial 
wattage was subjectively determined during a self-selected 5-minute warm-up. 
Subjects selected an intensity  that could be maintained for 90 minutes at  “easy to 
moderate intensity.”  Following warm-up, workload was incrementally increased 
by 20 W every 3 minutes until volitional fatigue or until subjects could not longer 
maintain a pedaling cadence ≥ 50 revolutions per minute.  VO2, RER, and VE 
were continuously  monitored with a Sensormedics Spectra (Yorba Linda, CA) 
metabolic cart.  Heart rate was monitored throughout each test using a Polar heart 
rate monitor (Lake Success, NY).  Blood lactate levels were assessed in the final 
minute of each exercise stage using a YSI 2300 STAT glucose/lactate analyzer 
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(Yellow Springs, OH) to determine lactate threshold, after which blood sampling 
was discontinued.  RPE was obtained in the final minute of each exercise stage 
and wattage at VO₂max was used to determine workloads during the 
familiarization and treatment trials.
Familiarization and Treatment Trials
 Each subject performed five trials over the course of nine weeks.  The 
preliminary trial served as a familiarization trial while the remaining four trials 
were the treatment trials (TT).  The general study design is outlined in Figure 3.1. 
The four treatment trials were conducted using a randomized, double-blind, cross-
over design and the two three-week supplementation phases were separated by a 
14-day washout period.  The first two treatment trials occurred before and after 
three weeks of supplementation with either placebo or SR2W-1.  Following the 
washout phase, subjects completed two more treatment trials conducted before 
and after three weeks of supplementation (placebo or SR2W-1, depending on first 
phase).  All trials were performed at ambient temperatures of 21-22°C.  An 
oscillating fan, set on ‘medium’ speed, was placed 2 meters from the handlebars 
of the cycle ergometer for cooling purposes during trials.  Subjects were 
instructed to perform each trial as a competitive event.
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Figure 4.1: Study Design
 A visual representation of the exercise protocol is displayed in Figure 3.2. 
Subjects reported to the lab in the morning after a 10-12 hour overnight fast.  To 
standardize for posture-related hemodynamics, subjects laid down for ten minutes 
prior to blood flow measurements.  During that time, an indwelling catheter was 
inserted into the arm while their right leg was prepared for a muscle biopsy 
(Lidocaine, incision, and bandaging). Resting blood flow was then assessed by the 
same investigator using a Shenzen Mindray DC-6 (Shenzen, Nanshan, China) 
5-10 MHz duplex ultrasound machine.  
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Figure 4.2: Treatment Trial Protocol
 Following catheter insertion, biopsy preparation, and femoral ultrasound, 
subjects performed a 3-minute warm-up at 100 watts, after which the subjects 
rode for 20 minutes at a fixed-wattage that elicited 85% of the subject’s VO2max. 
Immediately  following the 20-minute ride, subjects completed three one-minute 
intervals at 100% of wattage at VO2max with 30-seconds of active recovery at 100 
watts between each interval.  Following the final interval, subjects stopped 
cycling and began a 15-minute recovery  phase during which the subject 
underwent a muscle biopsy (1 minute into recovery) and femoral artery 
ultrasound (8 minutes into recovery).  Following recovery, subjects cycled at 
100% wattage at VO2max until volitional fatigue (cadence ≥ 50 RPM).
Exercise Performance
 Performance was measured by cycling duration (seconds) during the time 
to fatigue portion of the treatment trial.
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Muscle Biopsy
 Muscle biopsies were obtained from the VL during the 15-minute recovery 
period of all treatment trials (10).  The biopsy was taken within 1 minute of 
dismounting the ergometer in order to capture the metabolic state of muscle 
immediately after exercise.  The muscle sample was quickly trimmed of excess 
adipose tissue and frozen in liquid nitrogen in order to halt metabolism.  Each 
sample was then stored at -80℃ for later analysis of muscle lactate.  The subject 
was re-bandaged in order to complete the ride to exhaustion.
Muscle Lactate
 Muscle samples from each treatment trial were thawed to -20 to -15℃ and 
cut into 15-30 mg pieces using a refrigerated scale.  Samples were then frozen 
again to -80℃, transferred to a glass culture tube containing 0.5 ml 3 M 
perchloric acid (PCA) solution, homogenized, diluted with 1 M glycine/hydrazine 
stock (pH 9.8 - 10), and homogenized again.  NADH was then measured using a 
spectrophotometer at 340 nm.  Muscle lactate values were calculated 
mathematically based on fluorescence results (17).
Blood Lactate, pH, and Glucose
 Preceding each exercise trial, an indwelling antecubital venous catheter 
was inserted by a phlebotomy-trained investigator.  During exercise, the catheter 
was flushed periodically  with an injectible saline solution to prevent coagulation. 
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Blood samples were obtained at the following time points: minutes 10 and 20 of 
the 20-minute fixed intensity ride, immediately following the second high-
intensity interval, and minutes 1.5, 3, 6, 9, 12, and 15 of recovery.  Glucose and 
lactate levels were measured immediately from whole blood using a YSI 2300 
STAT glucose/lactate analyzer (Yellow Springs, Ohio).
VO2, RER, and Ventilation
 VO2, RER, and Ventilation were assessed at minutes 10 and 20 during the 
fixed-intensity ride and after the second high-intensity interval.  A SensorMedics 
Spectra (Yorba Linda, CA) metabolic cart  was used to monitor breath-by-breath 
gas exchange and average respiratory data over thirty seconds.
Heart Rate
 Heart rate was recorded at minutes 10 and 20 during the fixed intensity 
ride, after the second high-intensity  interval, and at minutes 3, 6, 9, and 12 during 
the recovery phase using a Polar heart rate monitor (Lake Success, NY).
Ratings of Perceived Exertion (RPE)
 Subjective ratings of exertion were obtained by  having the subject point to 
the corresponding exertion level on a Borg RPE scale (numerically  rated from 
6-20).  RPE was obtained at  minutes 10 and 2 of the fixed intensity ride and after 
the second high-intensity interval.
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Blood Flow
 Left femoral artery peak velocity  and diameter was measured 5-7 mm 
below the inguinal crease using a Mindray  DC-6 (Nanshan, Shenzen, China) 5-10 
MHz duplex ultrasound machine.  Blood flow was calculated using the equation: 
∏r² (mm) x peak velocity (cm/s) x 60 seconds.  Pre-exercise peak velocity and 
diameter was assessed at rest and post-exercise measurements were obtained eight 
minutes following the completion of the high-intensity intervals.
Supplement
 Subjects received either 1000 mg/day of SR2W-1 and 1000 mg/day of 
placebo in randomly assigned order.  Subjects ingested 2 x 500 mg capsules every 
morning for 21 days during the supplementation periods.  To promote 
supplementation compliance, subjects were required to text, e-mail, or call a 
member of the investigative team immediately after supplementation.  SR2W-1 is 
a proprietary  blend of herbs and fungi (primary ingredients: Enoki mushroom, 
Eleuthero extract, Reishi mushroom, tangerine extract, Cordyceps mushroom, and 
Asian Ginseng).  The placebo was provided by Radix BioResearch and was in 
capsule form identical to SR2W-1.
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Dietary and Exercise Controls
 Throughout the duration of the study, subjects were instructed to: 1. 
Maintain consistent dietary habits for 72 hours prior to each trial, 2.  Complete a 
diet record (Appendix V) for the 24 hours preceding each trial, 3.  Avoid heavy 
exercise for 48 hours prior to each trial, 4.  Maintain consistent physical activity 
habits starting 72 hours prior to the first treatment trial until the completion of the 
final treatment trial (~55 days), and 5.  Record all physical activity performed 
during the 24 hours preceding each trial (Appendix VI).  Subjects consumed their 
final ‘self-selected’ meal no less than 10 hours prior to the start of treatment trials 
(i.e. dinner on the evening prior to testing) and were allowed to consume only 
water ad libitum until the end of each treatment trial (total of ~10-12 hours of 
fasting with water intake).
Statistical Analyses
 Due to the small sample size in this study, data was analyzed with 
Wilcoxon Signed Rank tests utilizing change scores for each dependent variable 
from pre- to post- supplementation under EXP and PLA conditions.  Specifically, 
differences between pre- and post-supplementation cycling time to fatigue, 
muscle lactate, blood lactate, blood glucose, VO2, RER, VE, HR, and skeletal 
muscle blood flow were compared between treatments at a given time point 
during exercise.  Significance was set at p < 0.05.  All blood lactate data 
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during recovery was analyzed using differences in area underneath the curve. 
Results are reported as means ± SE.
RESULTS
Exercise Performance
! Time to fatigue was not differentially impacted by  PLA and EXP 
supplementation .  Individual performance times are displayed in Figure 4.3 (pre-
PLA: 180 ± 48 sec;  post-PLA: 198 ± 56;  pre-EXP: 170 ± 57;  post-EXP: 191 ± 
50).
Skeletal Muscle Lactate
 PLA and EXP supplementation did not differentially affect skeletal muscle 
lactate levels during recovery.  Muscle lactate levels are displayed in Figure 4.4 
(pre-PLA: 13.8 ± 2.4 mmol/kg wet wt; post-PLA: 13.0 ± 2.1; pre-EXP: 14.3 ± 
2.0 ; post-EXP: 12.8 ± 2.2).
Blood Lactate and Glucose
 Blood lactate and glucose levels were not  differentially impacted by  PLA 










































































































Table 4.2 Blood Glucose and Lactate Levels Before and After 
Supplementation
Placebo Experimental
Time (min) Variable Pre Post Pre Post
10
Glucose (mg/dL) 75.9 ± 4.0 72.0 ± 3.2 76.7 ± 3.3 71.5± 3.1
Lactate (mmol/L) 3.0 ± 0.5 2.7 ± 0.3 3.2 ± 0.3 3.1 ± 0.5
20
Glucose (mg/dL) 80.1 ± 4.1 75.2 ± 3.2 82.2 ± 3.2 76.9 ± 2.4
Lactate (mmol/L) 3.5 ± 0.6 3.2 ± 0.5 3.7 ± 0.3 3.6 ± 0.5
22:30
Glucose (mg/dL) 83.0 ± 4.1 77.5 ± 2.5 86.0 ± 3.2 80.9 ± 2.6
Lactate (mmol/L) 4.7± 0.7 4.3 ± 0.6 5.0 ± 0.4 4.6 ± 0.6
15-min recovery 
AUC Lactate (mmol/L) 56.7 ± 12.6 55.1 ± 11.3 60.5 ± 8.2 57.0 ± 12.7
AUC = Area Under the Curve
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VO2, RER, and Ventilation
 PLA and EXP supplementation did not differentially impact VO2 (ml/min 
and mL/kg/min), RER, or VE (L/min).  VO2, RER, and VE are displayed in Table 
4.3.  
Table 4.3 VO2, RER, and VE Before and After Supplementation
Placebo Experimental
Time (min) Variable Pre Post Pre Post
10
VO2 (L/min) 3.4 ± 0.4 3.4 ± 0.3 3.5 ± 0.3 3.4 ± 0.3
VO2 (ml/kg/min) 49.0 ± 3.5 50.7 ± 3.1 51.2 ± 3.8 50.6 ± 4.0
RER 0.91 ± 0.01 0.92 ± 0.01 0.91 ± 0.01 0.93 ± 0.02
VE (L/min) 85 ± 7 87 ± 6 91 ± 8 92 ± 8
20
VO2 (L/min) 3.4 ± 0.3 3.5 ± 0.3 3.5 ± 0.3 3.4 ± 0.3
VO2 (ml/kg/min) 49.6 ± 3.3 51.1 ± 2.9 51.2 ± 3.4 50.5 ± 3.4
RER 0.89 ± 0.01 0.89 ± 0.02 0.91 ± 0.01 0.89 ± 0.01
VE (L/min) 89 ± 6 91 ± 6 99 ± 8 93 ± 6
22:30
VO2 (L/min) 3.5 ± 0.3 3.6 ± 0.3 3.4 ± 0.4 3.5 ± 0.3
VO2 (ml/kg/min) 51.1 ± 2.1 53.0 ± 2.2 52.3 ± 2.8 52.2 ± 2.8
RER 0.99 ± 0.02 0.97 ± 0.03 0.97 ± 0.02 0.97 ± 0.03
VE (L/min) 107 ± 6 109 ± 7 117 ± 6 112 ± 6
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Heart Rate and Ratings of Perceived Exertion
 Heart rate and RPE numbers were not differentially impacted by PLA and 
EXP supplementation.  HR and RPE are displayed in Table 4.4.
Table 4.4 Heart Rate and RPE Before and After Supplementation
Placebo Experimental
Time (min) Variable Pre Post Pre Post
10
HR (bpm) 171 ± 5 169 ± 4 173 ± 5 172 ± 6
RPE 14.9 ± 0.3 14.1 ± 0.5 14.9 ± 0.5 14.8 ± 0.6
20
HR (bpm) 175 ± 4 173 ± 4 177 ± 5 177 ± 5
RPE 16.7 ± 0.6 15.9 ± 0.5 16.4 ± 0.4 16.1 ± 0.7
22:30
HR (bpm) 184 ± 4 182 ± 4 185 ± 4 183 ± 5
RPE 18.3 ± 0.5 17.7 ± 0.6 17.7 ± 0.7 17.9 ± 0.7
3R HR (bpm) 100 ± 6 104  ± 6 107 ± 5 104 ± 5
6R HR (bpm) 96 ± 7 97 ± 4 98 ± 5 98 ± 4
9R HR (bpm) 95 ± 4 92 ± 4 95 ± 4 98 ± 6




Blood flow (L/min) was not differentially  impacted by PLA and EXP 
supplementation .  Blood flow is displayed in Table 4.5.
Table 4.5 Blood Flow (L/min)
PLA EXP




Supplementation 1.1 ± 0.1 1.6 ± 0.1 1.1 ± 0.1 1.5 ± 0.2
Post 
Supplementation 1.2 ± 0.1 1.5 ± 0.2 1.2 ± 0.1 1.7 ± 0.1
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DISCUSSION
 The primary aims of this study were to evaluate the effect of the herbal 
supplement SR2W-1 on high-intensity cycling performance as well as blood and 
skeletal muscle lactate metabolism. Blood glucose, VO2, RER, VE, HR, RPE, and 
femoral artery blood flow were also observed to further elucidate the effects of the 
supplement.  We hypothesized that SR2W-1 supplementation would prolong 
cycling time to fatigue, reduce blood lactate levels during varying intensities of 
cycling exercise and during exercise recovery, and reduce skeletal muscle lactate 
levels and increase blood flow during recovery.  Contrary to our hypotheses, the 
collective results indicate that SR2W-1 does not affect time to fatigue, blood or 
muscle lactate levels, or any of the aforementioned physiological parameters. 
Therefore, SR2W-1 supplementation does not appear to be an effective ergogenic 
stategy, at least in the context of high-intensity cycling.
 Despite some evidence supporting the efficacy of herbal supplementation 
(7, 56, 57), the performance findings in this study are consistent with the larger 
body of literature.  Only one study has evaluated the impact SR2W-1 
supplementation on cycling performance, which reported that 60,000 Joule time 
trial performance was unchanged (57).  It is worth noting that the authors did not 
implement a cross-over design and could not account for individual variations in 
performance.  However, the study did implement a five-week supplementation 
phase (versus 21 days in the current study), which would theoretically maximize 
the treatment effect.  At least  ten other studies evaluated the efficacy of one of the 
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primary constituents of SR2W-1 (Cordyceps sinensis, Eleutherococcus senticosus, 
or Panax Ginseng), eight of which reported no change in cycling time to 
exhaustion, time trial performance, or anaerobic power output.  Thus it  is logical 
that SR2W-1, with all constituents combined, would not yield performance 
benefits.
 The effects of one to eight weeks of Panax Ginseng (PG) supplementation 
at varying dosages was investigated by Morris (73), Allen (3), and Engels (25-27). 
All five studies reached the similar conclusion that PG supplementation does not 
benefit cycling performance.  The different supplementation schemes and similar 
testing protocols (high-intensity rides to exhaustion or graded exercise tests) 
provide compelling evidence that PG is not ergogenic. Research regarding the 
efficacy of Eleutherococcus senticosus (ES) on cycling performance is scant and 
inconclusive.  Specifically, Eschbach et al. reported that 10-km time trial 
performance was unaffected by 7 days of ES supplementation (1200 mg/day) 
when compared to a placebo (29).  In contrast, a subsequent study implemented a 
much longer supplementation period (8 weeks) with lower dosing (800 mg/day) 
and observed improvements in cycling time to exhaustion with ES (56).  Another 
relevant investigation, albeit with glaring methodological limitations (single blind, 
possible learning effect), reported that time-to-exhaustion was enhanced with ES 
(7).  It is possible that ES may be ergogenic during high-intensity  cycling but 
further research involving different supplementation periods and dosages is 
required before drawing firm conclusions.   
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 The results of studies investigating Cordyceps senesis (CS) and cycling 
performance consistently show no ergogenic effect.  Three CS supplementation 
studies implementing exhaustive protocols of less than one hour found no 
increase in time to exhaustion or time trial performance (15, 23, 76).  Although 
findings are not unanimous, the preponderance of literature suggest the primary 
constituents of SR2W-1 do not benefit cycling performance of short duration (<60 
min) which is substantiated by the results of the current study.  
 It is well-established that high-intensity cycling performance benefits from 
lower blood lactate levels, as illustrated by the efficacy of bicarbonate 
supplementation (11, 18, 47, 60, 62, 66, 67, 69, 77).  However, to our knowledge, 
only one study has provided any evidence to suggest that  blood lactate levels are 
diminished by  herbal supplementation in the context of cycling.  Specifically, 
Lahr and colleagues documented that SR2W-1 provision reduced lactate levels 
during recovery  from intense cycling.  The authors speculated that less stress was 
placed on the HCO3- buffering system with supplementation (57).  However, it 
should be noted that Lahr’s study did not use a cross-over design and can not 
completely account for individual variation in performance. 
 Beyond the cycling-specific literature, a few studies have reported altered 
lactate metabolism during high-intensity exercise with herbal supplementation. 
Morrissey  el al tested a complex herbal formulation using a double-blind, 
randomized, placebo-controlled design and found that lactate was lower during 
recovery from intense treadmill running (74).  Further, Wu et al tested the efficacy 
79
of Ciwujia (ES) with high-intensity exercise and found lactate to be lower during 
recovery while potentially promoting glycogen sparing (101).  However, it should 
be noted that Wu’s study, much like Lahr’s, did not employ a cross-over design. 
The majority of studies, however, indicate blood lactate is not affected by PG (3, 
27, 73), CS (23), ES (29), or alternative herbal (20, 52) supplementation.  Further, 
to our knowledge, our study was the first to examine skeletal muscle lactate levels 
after herbal supplementation.  Considering the close association of blood to 
muscle lactate levels at comparable observed time points (r = 0.67 - 0.91) in our 
investigation, our novel findings confirm the validity of measuring blood lactate 
to determine the state of muscle during exercise and reinforces the reliability  of 
our testing procedures.  Provided the positive effect that lowered lactate has on 
performance, the lack of alteration in blood or muscle lactate levels are consistent 
with our performance findings as well as those found in the literature. 
 Of the studies that  have evaluated similar physiological parameters (VO2, 
RER, VE, HR, RPE, blood glucose, and skeletal muscle blood flow), there has 
only been one report suggesting that herbal supplementation modifies high-
intensity cycling physiology.  Kuo et al. found that VO2peak and highest heart rate 
attained increased while RPE and RER decreased during a 75% VO2peak ride to 
exhaustion with ES supplementation  (56).  Other data suggests VO2 (27, 29, 52, 
73), RER (27, 52, 73), VE (15, 76), HR (3, 20, 23, 27, 29, 52), RPE (3, 20, 27, 29, 
52), or blood glucose (29, 52, 73) remain unchanged with herbal supplementation. 
Although Colson et al evaluated the effects of Cordyceps sinensis on circulatory 
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dynamics during cycling and found no significant changes in tissue oxygenation 
(15) we are the first to examine femoral artery blood flow in response to herbal 
supplementation.  Increased blood flow to working skeletal muscle could 
theoretically facilitate lactate clearance from skeletal muscle (8).  However, our 
findings suggest that blood flow is not affected by SR2W-1 supplementation, 
which may or may not have contributed to our null performance and lactate 
findings.
 Contrary  to our hypotheses, the results of the current study  are consistent 
with the existing literature, which collectively indicates that herbal 
supplementation is not  effective at improving cycling performance or altering 
lactate levels.  In addition, supplementing with SR2W-1 does not alter VO2, RER, 
VE, RPE, blood glucose, or arterial blood flow during/following high-intensity 
cycling.  The small sample size, supplementation adherence, and training 
stipulations associated with the study  present limitations to the generalizability  of 
our findings.  However, the double-blind, placebo-controlled, cross-over design of 
our study, in concert with the intensity  of the cycling protocol and numerous 
physiological parameters investigated, provides a strong basis for our conclusion 




 The primary aims of this study were to evaluate the effect of SR2W-1 
supplementation on high-intensity cycling performance, blood and muscle lactate 
levels, and a host of other physiological parameters (i.e. blood glucose, VO2, 
RER, VE, HR, RPE, and skeletal muscle blood flow) utilizing a randomized, 
double-blinded, placebo-controlled crossover design.  We hypothesized that 
SR2W-1 supplementation would: 1) improve time to fatigue compared to a 
placebo, 2) elicit lower blood lactate levels during a 20-minutes fixed-intensity 
ride, high-intensity intervals, and recovery  compared to a placebo, 3) elicit  lower 
skeletal muscle lactate levels during 15-minutes of passive recovery from high-
intensity cycling compared to a placebo, 4) increase skeletal muscle blood flow 
compared to a placebo.  
 Contrary  to our hypotheses, SR2W-1 did not improve high-intensity 
cycling performance or decrease blood or skeletal muscle lactate levels. 
Furthermore, there were no differences in blood glucose, VO2, RER, VE, HR, 
RPE, and skeletal muscle blood flow with SR2W-1 supplementation compared to 
placebo.  Some possible explanations for a lack of efficacy include, but are not 
limited to, a short supplementation period of 21 days, short  duration of the cycling 
protocol, difficulty adhering to the supplementation (pill ingestion every  day) and 
training stipulations (maintenance of training intensity and duration throughout 
the study) required for participation, and a small sample size (n = 7).  
Notwithstanding these limitations, our findings indicate that SR2W-1 
supplementation is of little ergogenic value.
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The Human Performance Laboratory  at JMU will be conducting a study 
examining the effects of an herbal sports supplement on cycling performance, 
muscle function, and lactate dynamics.    
Who are we looking for?
-   Males and Females
-   18-55 years old
-   Cyclists (individuals performing cycling exercise on a regular basis – at least  
     3x wk)
What you will be asked to do:
-   Complete preliminary fitness testing/screening (60-90 minutes)
-   Participate in 5 exercise protocols (60-90 minutes), each of which consists of a 
3 minute warm-up, 20-minutes of hard riding, 3 x 1-minute high intensity 
intervals, 15 minutes of recovery, and a high intensity ride to fatigue lasting 
approximately 5 minutes (~30-35 of total exercise)
-   Receive laboratory assessments (including small blood draws, a muscle 
function test or small muscle biopsy) during each trial
-   Supplement for 21 days with an all-natural sports formula and a placebo (each 
21-day supplementation period is separated by 10 days)
What are the benefits of participation?
-   Free evaluation of aerobic capacity (VO2max) and physiological data 
-   $150 to $250 (biopsy subjects) for study completion
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For more information, please contact Dr. Nick Luden at ludennd@jmu.edu or Dr. 





Consent for Investigative Procedure
Purpose
You are being asked to volunteer for a research project conducted by Dr. Nick Luden, Dr. Michael 
Saunders, Dr. Christopher Womack, Kevin Murach, and Tara Ata from James Madison University 
titled “The Effects of an Herbal Supplement on Human Cycling Performance, Muscle Function, 
and Lactate Dynamics”.  
The primary aim of the current project is to examine the influence that 21-days of SR2W-1 sports 
formula supplementation has on cycling performance,  muscle function, and lactate dynamics. 
Information gained from this project will help determine the efficacy of SR2W-1 as well as 
indicate the underlying changes that are responsible for gains in cycling performance.  
Experimental Procedures
You will be asked to report to James Madison University’s Human Performance Laboratory 
(Godwin 209) for a total of six trials.  Specifically,  you will be asked to report to the laboratory for 
one pre-testing/screening trial,  one familiarization trial,  and four treatment trials.  Each of the six 
trials will last approximately 60-90 minutes in duration.  Detailed information for each of these 
trials is provided below:
Pre-testing/Screening (n = 1 trial)
Before any physical evaluation is given, pre-screening forms will be completed to ensure that you 
meet the study criteria, that you do not have any risk factors for heavy exercise, and that you do 
not have any known allergies to local anesthesia.   In the process of filling out these forms, you 
will be asked to share information regarding your general health and lifestyle with the researchers. 
If you meet the criteria for the study, the researchers will measure your height and weight and you 
will perform a cardiorespiratory fitness test.  During this assessment, an exercise test will be 
conducted to determine your maximal oxygen uptake (VO2max).   To do this, you will ride a 
stationary cycle at an initial workload that is ‘fairly easy’.   Workload will be increased every few 
minutes during the test.   You will be encouraged to continue to cycle until you request to stop due 
to fatigue or are unable to continue at a cadence >50 revolutions per minute.   Finger sticks to 
obtain blood for analysis of glucose and lactate will be taken every two minutes during exercise 
until fatigue.  In order to be included as a participant in the study, you must achieve a VO2peak of ≥ 
40 ml/kg/min if female or ≥ 45 ml/kg/min if male.   If you meet these criteria, you will be asked to 
report back to the laboratory for a familiarization trial.  
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Familiarization Trial: (n = 1 trial)
Within 14 days of the pre-testing trial, you will be asked to report to the laboratory for a 
familiarization trial.  This trial will be identical to the treatment trials, with the exception that no 
blood or muscle biopsy samples will be taken.  Please see the detailed description of the treatment 
trials for a more complete understanding of the familiarization trial, noting again that no blood or 
muscle biopsy samples will be taken.    
Treatment Trials: (n = 4 trials)
Within 5-14 days of the familiarization trial, you will be asked to perform the first of four 
treatment trials (TT).  The treatment trials will take place before and after 21 days of sports 
formula supplementation and before and after 21 days of placebo supplementation.  You will be 
randomly assigned to receive either 1000 mg/day of SR2W-1 or 1000 mg/day of placebo.   The 
SR2W-1 supplement is an all-natural sports formula comprised of herbal and fungi extracts and 
the placebo capsule will look identical but will be filled with flour.   You will be asked to ingest 2 
x 500 mg capsules every morning for 21 days.  To confirm compliance to supplementation, you 
will be asked to text, e-mail, or call a specified member of the investigative team once a day after 
the second ingestion (42 separate contacts).  Ten days following the first 21-day supplementation 
period (and treatment trial) you will be asked to replicate the first portion of the study with the 
alternative supplement (placebo or SR2W-1).   See next page for a general study schematic.    For 
each treatment trial, you will be asked to report to the laboratory in the morning after 10-12 hours 
of overnight fasting.   You will be permitted to drink water during the fast.
Treatment Periods:
Exercise Protocol
Each trial will last approximately 60-90 minutes in duration with the exercise protocol (shown 
below) lasting approximately 50 minutes.   Following a 3-minute warm-up, you will ride for 20-
minutes at a hard intensity (approximately 85% VO2peak), upon which you will be asked to 
complete 3 x 1 minute intervals at an intensity associated with your VO2peak (determined during 
the pre-testing trial).    Each of these intervals will be separated by 30 seconds of riding at the same 
intensity as the preceding 20-minute ride.   Following the final interval you will be provided with 
15 minutes of recovery.   The recovery phase will be followed by a ride until fatigue performed at 
an intensity associated with your VO2peak.   You are encouraged to treat this aspect of the trial as if 
it is a competitive event and to ride until you voluntarily stop or until you can no longer continue 




A catheter will be inserted into a vein in the upper forearm approximately 10 minutes prior to the 
exercise protocol.    15 blood draws will be performed at various timepoints during the protocol 
and the catheter will remain in place until after the final blood draw.   The catheter minimizes the 
number of times that a needle is inserted.   During each sample, small amounts of blood (~3 
milliliters) will be obtained and utilized to measure lactate, pH, and glucose.  The total amount of 
blood obtained during each trial will be approximately 39 ml or 180 ml over the course of the 
entire study.  This amount is similar to 50% of a can of soda or 38% of the amount given when 
donating blood in a single session.  
Metabolic Measurements
Metabolic measurements such as oxygen uptake, ventilation, etc. will be measured using a 
SensorMedics metabolic cart.   To do this, you will be asked to breathe through a mouthpiece/
breathing apparatus that collects your expired breath during the entire 20-minute fixed-intensity 
ride.
Ratings of Perceived Exertion
You will be asked to provide subjective ratings of your exertion level at various timepoints 
throughout the exercise protocol.   You will do this by pointing to your corresponding level of 
exertion (rated numerically from 6-20) on a Borg RPE scale.   
Heart Rate
Your heart rate will be measured using a Polar heart rate monitor that will be worn around your 
chest during each exercise session.   
Skeletal Muscle Circulation
During the 15-minute recovery period, thigh blood flow may be measured with ultrasound 
equipment – similar to what is done during fetal examinations during pregnancy.   Ultrasound gel 
will be applied to your quadriceps and a plastic ultrasound probe will be held in contact with the 
skin for only a few minutes.   
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In addition to the measures outlined above, you are being asked to volunteer for either a 
muscle function - central fatigue test OR a thigh muscle biopsy, as described below.   The 
muscle function-central fatigue test will be performed during the familiarization trial and 
each treatment trial, while the muscle biopsy will only be performed during each treatment 
trial.
Muscle Function – Central Fatigue Test
You will be asked to complete a maximal strength test prior to each trial, immediately following 
the 3 x 1-minute intervals and towards the end of the 15-minute recovery period.  During this test, 
you will be seated in a modified chair,  and asked to push as hard as possible against a shin pad that 
will be connected to a force transducer for 4 repetitions with a minute rest in between.   During 
this strength test, you will also perform an electrically stimulated contraction.  Two adhesive 
patches will be placed on the skin of your thigh.   These electrodes will be used to apply electrical 
stimulation to the thigh muscle at an intensity, which produces a contraction force equal or greater 
to what you can generate on your own.  The stimulation intensity will be set below the maximum 
stimulation intensity you can tolerate, similar to a TENS unit used in physical therapy.
________    I agree to participate in the muscle function – central fatigue test 
Muscle Biopsy
A total of 4 muscle biopsies (one biopsy during each treatment trial) from the thigh will be 
obtained for this study protocol.  Prior to each biopsy, the skin at the biopsy site will be cleaned 
with povidone-iodine topical anti-septic and numbed by an injection of a local anesthetic (similar 
to what is done at the dentist).  When the area is numb (5 minutes), a small 1/4 inch incision will 
be made in the skin and a needle will be inserted briefly (2-3 seconds) into the muscle to remove a 
piece of muscle about the size of a pea.  The incision will be pulled closed with a band-aid and the 
area over the incision will be covered with an elastic pressure bandage.  The entire procedure will 
take a total of approximately 10-15 minutes, with the actual biopsy lasting only a few seconds.  
________    I agree to participate in the muscle biopsy procedure
Dietary and Exercise Controls  
You are to maintain consistent dietary habits for 72 hrs prior to each trial, and to complete a diet 
record (see Attachment 4) for the 24 hrs preceding each trial.  While avoiding heavy exercise for 
48 hrs prior to each trial, you will also be asked to maintain consistent physical activity habits 
starting 72 hrs prior to the first treatment trial until the completion of the final treatment trial (~55 
days), and to record all physical activity performed during the 72 hrs preceding each trial (see 
Attachment 5).  You are to consume your final ‘self-selected’  meal no less than 10 hrs prior to the 
start of the treatment trials (i.e. dinner on the evening prior to testing).   After this time, you are to 
consume only water ad libitum until the end of each treatment trial (a total of ~11 to 13 hrs of 
fasting with ad libitum water intake).   
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Risks
You are expected to be honest about disclosing all known risk factors to the researcher.  There are 
no known risks associated with supplementing with the SR2W-1 sports formula.  However, there 
are some risks associated with high does of some ingredients in isolation. SR2W-1 is a proprietary 
blend of herbs and fungi (primary ingredients: Enoki Mushroom, Eluthero Extract, Reishi 
Mushroom, Tangerine Extract, Cordyceps Mushroom, and Asian Ginseng).  Although highly 
unlikely, it is possible that one or more of the ingredients can adversely impact pathophysiological 
conditions (blood clotting disorders such as hemophilia or thrombocytopenia) or medications 
(Coumadin, digoxin/digitalis).  You will be pre-screened for each of the aforementioned conditions 
as well as for known allergies to the ingredients.  You will also be provided with an adverse event/
side effect form for you to record any adverse effects of supplementation.
According to the American College of Sports Medicine,  the risks associated with maximal 
exercise/testing for healthy individuals are very minimal.   If you do not meet the criteria for “low 
risk”, you will not be allowed to participate in the study.   In the unlikely event of cardiac or other 
complications during exercise, an emergency plan is in place.   This includes immediate access to 
a phone to call emergency personnel.   In addition, each of the investigators is CPR certified.   
The exercise protocol may result in minor-moderate levels of muscle soreness and fatigue for 1-2 
days following each exercise session.   However, the level of muscle soreness is expected to be 
lower than levels normally experienced when people perform other ‘normal’ activities that are not 
part of their regular exercise routine (i.e. if a cyclist played a game of basketball with friends for 2 
hours).  
The risks of blood draws include possible mild bruising, and the risk of transfer of blood-borne 
pathogens.    This risk is considered to be very minimal, and all safety precautions for handing 
blood samples will be followed according to OSHA protocols.   The investigators have been 
trained in phlebotomy and completed JMU blood-borne pathogen training.  
The risks of the interpolated twitch technique include temporary “tingling” or “pulsing” sensation 
(for 1-2 seconds), which you may perceive as uncomfortable.  
The risks associated with the muscle biopsy technique include a possible dull pain during the 
administration of the anesthetic and the biopsy procedure, and delayed soreness for one to two 
days following the biopsy.  Sterile procedures will be used during the biopsy procedure to 
minimize these risks.  There is a small risk of bleeding, infection, and scarring of the skin. 
Temporary numbness of the skin near the biopsy site occurs rarely.  You may feel lightheaded and 
there is a slight risk of fainting.  Following the biopsy you will be provided with a ‘biopsy care 
package’ that will include instructions for care, band-aids, and alcohol pads.  As a precaution,  a 
member of our research team will contact you via phone or e-mail approximately 48-hrs following 
the biopsy to confirm that you are recovering/healing from the biopsy appropriately.  You are also 
encouraged to contact a member of our research team if you have any concerns about your 
recovery.   There is a small risk of an allergic reaction to the local anesthetic used during the 
muscle biopsy procedure.   Symptoms may include an itching sensation of the skin,  difficulty 
breathing, fainting,  and shock.  Allergic reactions to the local anesthetic used are extremely rare. 
You will be pre-screened, as part of the medical history document, for any known allergic reaction 




The benefits associated with this project include a free VO2max assessment, and a $150 payment 
for study completion.   If you volunteered to undergo the muscle biopsy procedure you will 
receive an additional $100 payment for study completion for a total of $250.   In the case that you 
freely withdraw from the study, payments will be pro-rated as follows: non-biopsy subjects = 
$37.50 for the completion of each treatment trial, biopsy subjects = $62.50 for the completion of 
each treatment trial.   
Inquiries
If you have any questions of concerns, please contact Dr. Nicholas Luden at ludennd@jmu.edu or 
(540) 568-4069.    In the case of any immediate concerns or adverse reactions during the study, 
contact Dr. Luden on his cell phone (540) 746-6134.  
Confidentiality
All data and results will be kept confidential.  You will be assigned an identification code.   At no 
time will your name be identified with your individual data.   The researcher retains the right to 
use and publish non-identifiable data.   All data will be kept secured in a locked cabinet.   Final 
aggregate results will be made available to participants upon request.   
Freedom of Consent
Your participation is entirely voluntary.   You are free to choose not to participate.   Should you 
choose to participate, you can withdraw at any time without consequences of any kind.
I have read this consent form and I understand what is being requested of me as a participant in 
this study.   I freely consent to participate.   I have been given satisfactory answers to my 
questions.   The investigator provided me with a copy of this form.   I certify that I am at least 18 
years of age.
Name of Subject  (Printed) Name of Researcher  (Printed)
Name of Subject  (Signed) Name of Researcher  (Signed)
  Date   Date
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For questions about your rights as a research subject, you may contact the chair of JMU’s 
Institutional Review Board (IRB).  Dr. David Cockley, (540) 568-2834, cocklede@jmu.edu.
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Appendix III
AHA/ACSM Health/Fitness Facility Pre-participation Screening Questionnaire
Assess your health status by marking all true statements
History
You have had:
   a heart attack
   heart surgery
   cardiac catheterization
   coronary angioplasty (PTCA)
If you marked any of these statements in 
this section, consult your physician or 
other appropriate health care provider 
before engaging in exercise.  You may 
need to use a facility with a medically 
qualified staff.
 
  pacemaker/implantable cardiac
   defibrillator/rhythm disturbance
   heart valve disease
   heart failure
   heart transplantation
   congenital heart disease
Symptoms
   You experience chest discomfort with exertion
   You experience unreasonable breathlessness
   You experience dizziness, fainting, or blackouts
   You take heart medications
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Other Health Issues
   You have diabetes
   You have asthma or other lung disease
   You have burning or cramping sensation in your lower 
   legs when walking short distances
   You have musculoskeletal problems that limit your 
   physical activity
   You have concerns about the safety of exercise
   You take prescription medication(s)
If you marked two or more of the 
statements in this section, you should 
consult your physician or other 
appropriate health care provider before 
engaging in exercise.  You might benefit 
from using a facility with a 
professionally qualified exercise staff to 
guide your exercise program.
Cardiovascular risk factors
   You are a man older than 45 years
   You are a woman older than 55 years, have had a 
   hysterectomy, or are postmenopausal
   You smoke, or quit smoking within the previous 6 months
   Your blood pressure is > 140/90 mmHg
   You do not know your blood pressure
   You take blood pressure medication
   Your blood cholesterol level is > 200 mg/dl
   You do not know your cholesterol level
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   You have a close blood relative who had a heart attack or
   heart surgery before age 55 (father or brother) or age 65
       (mother or sister)
   You are physically inactive (i.e. you get < 30 minutes of 
   physical activity on at least 3 days of the week)
   You are > 20 pounds overweight
You should be able to exercise safely 
without consulting your physician or 
other appropriate health care provider in 
a self-guided program or almost any 
facility that meets your exercise 
program needs.
“Negative risk factors”
   High-serum HDL Cholesterol ≥ 60 mg/dl




Please Complete the Following:




Average Exercise Habits over the Past 2 Months:
Avg. # days of exercise per week:
Avg. # of days of aerobic exercise per week:
   
Avg. # of days of cycling per week:   
Do you have a muscle or joint injury that precludes the completion of the exercise protocol? 
Do you currently use medications for relief of pain and/or soreness? 
Do you have a blood clotting disorder (haemophilia, thrombocytopenia, etc)?
Do you currently use blood-thinning medications (Coumadin, etc)?
Do you currently use cardiac medications (Digoxin, Digitalis, etc)?
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Are you a vegetarian?
Are you allergic to local anesthetics (numbing agents) such as Lidocaine (Xylocaine, 
Novocain, etc)?




 Subject number____________ 
 Date______________  Day of Week______________
Adapted From:  Lee RD, Nieman DC. Nutritional Assessment. 2nd ed. United 
States of America: Mosby; 1996
Time Food and/or Drink Method of Preparation Quantity Consumed Brand Name
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INSTRUCTIONS FOR KEEPING YOUR 24-HOUR  FOOD RECORD
Keep your record for three days per trial. You will include the day before, the day 
of, and the day after each trial.  Include all meals, snacks, nibbling, and beverages 
including water and cocktails
1.  Fill out the date and day of the week at the top of food record sheet
2.  Record the time you consumed your food and/or drink.  To be most 
accurate, fill out the food record as soon as you finish eating.
3.  List the first food and/or drink you consumed when you began your day 
and continue to record until you consume your last food and/or drink of 
your day (usually before bedtime)
4. List each food and/or drink on a separate line
 Example:  cereal with milk, cereal and milk should each be on 
 separate lines spaghetti, noodles and sauce should each be on 
 separate lines
  Combination foods:  
  List parts of food on separate lines
  Include preparation method, quantity, and brand name of each food
       Example:  Sandwich (4 oz healthy choice turkey, 2 slices Sara Lee  
       wheat bread, 1 tbsp Hellman’s light mayo, 2 oz Kraft American  
       cheese, 1 slice of red fresh tomato)
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5. Record the method of preparation
  Example:  fried, baked, grille, salt, oil (olive, canola, corn, other) 
  butter or margarine, spices, etc.
6. Record quantity consumed
  Do not record any food not eaten
  Example:  made two cups of vegetables but ate half so you would 
  record one cup
  Quantity of food and/or drink
  Example:  cups, ounces, liters, grams, each, or other unit of 
  measure
  Example:  1 cup of vegetables, 4 ounces of meat, one medium 
  apple
7. Record brand name
  Example:  fast food chain name and/or package name
  Example:  Wendy’s, Betty Crocker, Lean Cuisine, Gatorade, 
  Thomas Bagel
8. Place any helpful food labels in manila envelope that is attached to folder
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USE THE FOLLOWING TO HELP DETERMINE PORTION SIZES AND TYPES OF 
FOODS





Name of drink and ingredients (if mixed drink)
Breads Butter or margarine added?
Cereal/Milk
Milk, sugar, or fruit added?
The type of milk? (skim, 1%, 2%, whole)
Cereal:  dry or cooked measure?
Dairy
Is yogurt fruited or plain?
% fat of milk or yogurt?




Fat modified (i.e., reduced)?
Sugar-free?
Eggs Preparation method (scrambled, hard-boiled, etc)?Fat used in cooking?
Fast Food
What restaurant?
If not a national fast food chain, describe food in detail
Size order of fries?  Super-size?
Extra toppings on sandwich?
Fats/Oils
Regular or salt-free?
Stick, tub, or liquid margarine?
Reduced calorie or diet product?
Fish
Water or oil packed (fresh or canned)?
Baked or fried (With batter or without)?
Type of fat added?
Raw or cooked weight?
Fruit
Sweetened or unsweetened?
Fresh, canned, or frozen?
With or without skin?
Meats Visible fat removed?Light or dark meat?  Raw or cooked?
Sugars and Sweets Regular or reduced-calorie?Don’t forget hard candy as well as chocolate.
Vegetables
Raw or cooked?
Fresh, frozen, or canned?
Low-sodium or regular?
Added fat or sauce?
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Helpful Hints with Portion Sizes
• 1 teaspoon (5 ml) 
o about the size of the top half / tip of your thumb 
• 1oz (28g)
o approximately inch cube of cheese 
o volume of four stacked dice 
o slice of cheese is about the size of a 3 1/2 inch computer disk 
o chunk of cheese is about as thick as 2 dominoes 
o 1 handful (palm) of nuts 
• 2 ounces (57 g) 
o 1 small chicken leg or thigh 
o 1/2 cup of cottage cheese or tuna 
• 3 ounces (85 g) 
o serving of meat is about the size of a deck of playing cards (3 exchanges) 
o the size of the palm of your hand
o 1/2 of whole chicken breast 
o 1 medium pork chop 
o 1 small hamburger 
o unbreaded fish fillet 
• 1/2 cup (118 ml) 
o fruit or vegetables can fit in the palm of your hand 
o about the volume of a tennis ball 
• 1 cup (236 ml) 
o about the size of a woman's fist 
o breakfast cereal goes halfway up the side of a standard cereal bowl 
o broccoli is about the size of a light bulb 




Subject #    Trial #   Date:  





















Inventory of Supplies Necessary to Complete this Project
Pre-Screening Trials
Lactate Threshold Blood Analysis
Supplies Needed Brand and Item Number
Sterile Alcohol Prep Pads Fisher Brand:  06-669-62
Mini-capillary Blood Collection 
Tubes
Ram Scientific: 07 6101
Unistik Lancets Owen Mumford Ltd:  AT 1013 CE053
Kendal Versalon All-Purpose 
Sponges, 2 x 2




Supplies Needed Brand and Item Number
Excel Safelet Catheter Needles (20G 
x 1 1/4”)
Superior Silver: EP85465
Baxter Standard Bore 3-Way 
Stopcock
Med Specialties Distr.: 2C5600
Bacteriostatic 0.9% Sodium Chloride Hospira:  NDC 0409-1966-07
Monoject 6 mL Luer-Lok Syringes Tyco Healthcare:  1180600777
Kendal Versalon All-Purpose 
Sponges, 2 x 2




Supplies Needed Brand and Item Number
Biopsy Needle Stille:  119-29187-50
Crosstex self-sealing sterilization 
pouch
Fisher Brand:  01-312-51
Lidocaine HCl 0.1% Hospira:  NDL 0409-4276-02
BD 3 mL Syringe, Luer-Lok Tip Becton Dickinson:  309585
23G TW Needles, Precision Glide Becton Dickinson:  305193
Monoject Safety Needles, 20G x 1” Tyco Healthcare:  8881850010
Safety Lock carbon steel surgical 
blades
Bard-Parker:  371151
1” Durapore Tape 3M: 1538-1
Kendal Curity Gauze Sponges 4 x 4 Tyco Healthcare:  2187
Kendal Versalon All-Purpose 
Sponges, 2 x 2
Tyco Healthcare Group:  9022
Betadine Swab Stick Purdue Products:  NDC 67618-153-01
Poly lined sterile field Basse: 696
Elastikon Tape Johnson and Johnson:  005171
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Supplies Needed Brand and Item Number
Coban 3M:  NDC 8333-1582-01
Maxizyme Henry Schein:  101-9031
Kenal 140 mL Luer-Lok Syringe Tyco Healthcare:  8881114063




Supplies Needed Brand and Item Number
Disposable Scalpel, #10 Feather: 2975
Cryo Tube Vials Nunc:  375418
Petri Dishes for 47 mm cultures Fisher Brand:  09-720-500
Kendal Curity gauze Sponges 4 x 4 Tyco Healthcare:  2187
Dulmont Medial Tweezers, 110mm, 
#5
Ted Pella, Inc.:  38125
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